ShaoY_2019_ERR3405992_bin.9_k141_1637_7	CARD|gb|CYF42523.1|ARO:3004047|kdpD	29.0	217	425	885	9.13e-15	75.5
ShaoY_2019_ERR3405992_bin.9_k141_1637_8	NCBI|WP_011461303.1|1|1|vanR-I|vanR-I|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-I|AMR|glycopeptide	34.2	228	224	232	1.15e-30	112
ShaoY_2019_ERR3405992_bin.9_k141_1637_8	megares|MEG_7482|Drugs|Glycopeptide|VanL-type_regulator|VANRI_1	34.2	228	224	232	1.15e-30	112
ShaoY_2019_ERR3405992_bin.9_k141_1637_8	CARD|gb|AAC73788.1|ARO:3003841|kdpE	32.0	228	224	225	7.48e-30	109
ShaoY_2019_ERR3405992_bin.9_k141_1637_8	NCBI|WP_063856726.1|1|1|vanR-M|vanR-M|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-M|AMR|glycopeptide	32.6	227	224	232	1.74e-29	108
ShaoY_2019_ERR3405992_bin.9_k141_1637_8	megares|MEG_3448|Drugs|Aminoglycosides|Aminoglycoside_efflux_pumps|KDPE_1	32.0	225	224	225	2.92e-29	108
ShaoY_2019_ERR3405992_bin.9_k141_1637_8	NCBI|WP_063856723.1|1|1|vanR-B|vanR-B|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-B|AMR|glycopeptide	30.3	221	224	219	5.39e-28	104
ShaoY_2019_ERR3405992_bin.9_k141_1637_8	NCBI|WP_032489743.1|1|1|vanR-B|vanR-B|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-B|AMR|glycopeptide	30.3	221	224	220	5.52e-28	104
ShaoY_2019_ERR3405992_bin.9_k141_1637_8	NCBI|WP_002317273.1|1|1|vanR-B|vanR-B|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-B|AMR|glycopeptide	30.3	221	224	219	7.57e-28	104
ShaoY_2019_ERR3405992_bin.9_k141_1637_8	NCBI|WP_063856719.1|1|1|vanR-B|vanR-B|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-B|AMR|glycopeptide	30.3	221	224	220	7.75e-28	104
ShaoY_2019_ERR3405992_bin.9_k141_1637_8	NCBI|WP_002368697.1|1|1|vanR-B|vanR-B|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-B|AMR|glycopeptide	29.9	221	224	220	7.75e-28	104
ShaoY_2019_ERR3405992_bin.9_k141_1637_10	NCBI|XSG12260.1|1|1|drcA|drcA||1|||daptomycin_efflux_ABC_transporter_ATP-binding_protein_DrcA|AMR|peptide	39.7	219	221	255	1.76e-59	186
ShaoY_2019_ERR3405992_bin.9_k141_1637_10	SARG|gi|657888313|ref|WP_029592374.1|	46.6	219	221	648	2.31e-57	191
ShaoY_2019_ERR3405992_bin.9_k141_1637_10	SARG|gi|696368937|ref|WP_032943949.1|	46.1	219	221	648	2.31e-57	191
ShaoY_2019_ERR3405992_bin.9_k141_1637_10	SARG|gi|851913025|ref|WP_048215946.1|	46.1	219	221	648	2.31e-57	191
ShaoY_2019_ERR3405992_bin.9_k141_1637_10	SARG|YP_002850060	46.1	219	221	648	2.31e-57	191
ShaoY_2019_ERR3405992_bin.9_k141_1637_10	SARG|gi|489930965|ref|WP_003834285.1|	46.1	219	221	648	2.31e-57	191
ShaoY_2019_ERR3405992_bin.9_k141_1637_10	SARG|gi|696361545|ref|WP_032936694.1|	46.1	219	221	648	3.22e-57	190
ShaoY_2019_ERR3405992_bin.9_k141_1637_10	SARG|gi|489936909|ref|WP_003840216.1|	46.1	219	221	648	3.22e-57	190
ShaoY_2019_ERR3405992_bin.9_k141_1637_10	SARG|gi|507079862|ref|WP_016150620.1|	46.1	219	221	648	3.22e-57	190
ShaoY_2019_ERR3405992_bin.9_k141_1637_10	SARG|gi|949791377|ref|WP_057104572.1|	46.1	219	221	648	3.22e-57	190
ShaoY_2019_ERR3405992_bin.9_k141_1637_40	SARG|gb|WP_197749399.1|ARO:3005349|DfrA38	39.5	162	164	166	2.35e-29	104
ShaoY_2019_ERR3405992_bin.9_k141_1637_40	NCBI|WP_038694170.1|1|1|dfrA49|dfrA49|insensitivity|2|diaminopyrimidine|diaminopyrimidine|diaminopyrimidine-resistant_dihydrofolate_reductase_DfrA49|AMR|diaminopyrimidine	45.8	144	164	167	3.41e-29	104
ShaoY_2019_ERR3405992_bin.9_k141_1637_40	SARG|gb|CBL80435.1|ARO:3002869|dfrK	34.8	164	164	163	7.69e-27	98.2
ShaoY_2019_ERR3405992_bin.9_k141_1637_40	NCBI|WP_031775848.1|1|1|dfrK|dfrK|insensitivity|2|diaminopyrimidine|diaminopyrimidine|diaminopyrimidine-resistant_dihydrofolate_reductase_DfrK|AMR|diaminopyrimidine	34.8	164	164	163	7.69e-27	98.2
ShaoY_2019_ERR3405992_bin.9_k141_1637_40	NCBI|WP_012779617.1|1|1|dfrK|dfrK|insensitivity|2|diaminopyrimidine|diaminopyrimidine|diaminopyrimidine-resistant_dihydrofolate_reductase_DfrK|AMR|diaminopyrimidine	35.5	169	164	163	1.53e-26	97.4
ShaoY_2019_ERR3405992_bin.9_k141_1637_40	SARG|gb|BAE15963.1|ARO:3002868|dfrG	35.7	168	164	165	1.80e-25	94.7
ShaoY_2019_ERR3405992_bin.9_k141_1637_40	SARG|gb|CAF31623.1|ARO:3005354|dfr22	38.6	132	164	165	2.22e-23	89.4
ShaoY_2019_ERR3405992_bin.9_k141_1637_40	NCBI|WP_063844370.1|1|1|dfrA22|dfrA22|insensitivity|2|diaminopyrimidine|diaminopyrimidine|diaminopyrimidine-resistant_dihydrofolate_reductase_DfrA22|AMR|diaminopyrimidine	38.6	132	164	165	6.21e-23	88.2
ShaoY_2019_ERR3405992_bin.9_k141_1637_40	SARG|CAX16467	38.2	131	164	165	1.23e-22	87.4
ShaoY_2019_ERR3405992_bin.9_k141_1637_40	NCBI|WP_071846242.1|1|1|dfrA33|dfrA33|insensitivity|2|diaminopyrimidine|diaminopyrimidine|diaminopyrimidine-resistant_dihydrofolate_reductase_DfrA33|AMR|diaminopyrimidine	38.2	131	164	165	1.74e-22	87.0
ShaoY_2019_ERR3405992_bin.9_k141_1637_49	SARG|gi|488374619|ref|WP_002444004.1|	25.7	443	456	452	1.67e-43	157
ShaoY_2019_ERR3405992_bin.9_k141_1637_49	SARG|gi|686155635|ref|WP_031787393.1|	27.7	458	456	451	8.40e-43	155
ShaoY_2019_ERR3405992_bin.9_k141_1637_49	SARG|gi|446573718|ref|WP_000651064.1|	27.5	458	456	451	1.16e-42	155
ShaoY_2019_ERR3405992_bin.9_k141_1637_49	SARG|gi|686432388|ref|WP_031921070.1|	27.0	452	456	451	3.09e-42	154
ShaoY_2019_ERR3405992_bin.9_k141_1637_49	SARG|gi|1006223553|ref|WP_061745579.1|	26.8	452	456	451	4.28e-42	154
ShaoY_2019_ERR3405992_bin.9_k141_1637_49	SARG|gi|686309068|ref|WP_031870147.1|	27.0	452	456	451	5.92e-42	153
ShaoY_2019_ERR3405992_bin.9_k141_1637_49	SARG|gi|686448604|ref|WP_031928572.1|	25.9	448	456	451	8.20e-42	153
ShaoY_2019_ERR3405992_bin.9_k141_1637_49	SARG|ZP_03986195	26.5	452	456	451	1.13e-41	152
ShaoY_2019_ERR3405992_bin.9_k141_1637_49	SARG|gi|763462741|ref|WP_044292157.1|	27.0	452	456	451	1.13e-41	152
ShaoY_2019_ERR3405992_bin.9_k141_1637_49	SARG|gi|446573715|ref|WP_000651061.1|	26.8	452	456	451	1.13e-41	152
ShaoY_2019_ERR3405992_bin.9_k141_1737_37	NCBI|XSG12260.1|1|1|drcA|drcA||1|||daptomycin_efflux_ABC_transporter_ATP-binding_protein_DrcA|AMR|peptide	45.1	224	227	255	8.40e-62	192
ShaoY_2019_ERR3405992_bin.9_k141_1737_37	SARG|gb|AAV85982.1|ARO:3000535|macB	47.3	224	227	644	6.56e-61	200
ShaoY_2019_ERR3405992_bin.9_k141_1737_37	SARG|gi|639225329|ref|WP_024561799.1|	48.0	223	227	648	7.19e-60	197
ShaoY_2019_ERR3405992_bin.9_k141_1737_37	SARG|gi|639218559|ref|WP_024556062.1|	48.0	223	227	648	7.19e-60	197
ShaoY_2019_ERR3405992_bin.9_k141_1737_37	SARG|gi|746253210|ref|WP_039301529.1|	46.2	223	227	648	1.00e-59	197
ShaoY_2019_ERR3405992_bin.9_k141_1737_37	SARG|gi|1001720867|ref|WP_061274204.1|	46.2	223	227	648	1.00e-59	197
ShaoY_2019_ERR3405992_bin.9_k141_1737_37	SARG|gi|657888313|ref|WP_029592374.1|	47.5	223	227	648	1.40e-59	197
ShaoY_2019_ERR3405992_bin.9_k141_1737_37	SARG|gi|495736522|ref|WP_008461101.1|	46.2	223	227	648	1.95e-59	196
ShaoY_2019_ERR3405992_bin.9_k141_1737_37	SARG|gi|896325272|ref|WP_049294291.1|	47.1	223	227	648	5.30e-59	195
ShaoY_2019_ERR3405992_bin.9_k141_1737_37	SARG|gi|746243059|ref|WP_039291473.1|	46.2	223	227	648	7.39e-59	195
ShaoY_2019_ERR3405992_bin.9_k141_1737_38	NCBI|WP_063856732.1|1|1|vanS-G|vanS-G|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_histidine_kinase_VanS-G|AMR|glycopeptide	22.5	231	275	367	3.59e-12	64.7
ShaoY_2019_ERR3405992_bin.9_k141_1737_38	NCBI|WP_021418927.1|1|1|vanS-G|vanS-G|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_histidine_kinase_VanS-G|AMR|glycopeptide	22.5	231	275	368	3.60e-12	64.7
ShaoY_2019_ERR3405992_bin.9_k141_1737_38	NCBI|WP_063856737.1|1|1|vanS-B-Delta|vanS-B|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|VanB-type_glycopeptide_resistance_histidine_kinase_VanS-B-Delta|AMR|glycopeptide	22.9	188	275	441	4.96e-09	55.5
ShaoY_2019_ERR3405992_bin.9_k141_1737_38	NCBI|WP_002382867.1|1|1|vanS-B|vanS-B|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_histidine_kinase_VanS-B|AMR|glycopeptide	22.8	193	275	447	5.00e-09	55.5
ShaoY_2019_ERR3405992_bin.9_k141_1737_38	NCBI|WP_012579101.1|1|1|vanS-B|vanS-B|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_histidine_kinase_VanS-B|AMR|glycopeptide	22.8	193	275	447	5.00e-09	55.5
ShaoY_2019_ERR3405992_bin.9_k141_1737_38	NCBI|WP_063856739.1|1|1|vanS-B|vanS-B|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_histidine_kinase_VanS-B|AMR|glycopeptide	22.8	193	275	447	5.00e-09	55.5
ShaoY_2019_ERR3405992_bin.9_k141_1737_38	NCBI|WP_063856751.1|1|1|vanS-B|vanS-B|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_histidine_kinase_VanS-B|AMR|glycopeptide	22.8	193	275	454	5.04e-09	55.5
ShaoY_2019_ERR3405992_bin.9_k141_1737_38	NCBI|WP_002368696.1|1|1|vanS-B|vanS-B|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_histidine_kinase_VanS-B|AMR|glycopeptide	22.3	193	275	447	6.70e-09	55.1
ShaoY_2019_ERR3405992_bin.9_k141_1737_39	CARD|gb|ATC67679.1|ARO:3000838|arlR	39.2	222	221	219	1.21e-36	127
ShaoY_2019_ERR3405992_bin.9_k141_1737_39	NCBI|WP_063856721.1|1|1|vanR-A|vanR-A|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-A|AMR|glycopeptide	32.6	227	221	231	1.01e-34	122
ShaoY_2019_ERR3405992_bin.9_k141_1737_39	megares|MEG_7449|Drugs|Glycopeptide|VanA-type_regulator|VANRA_1	32.9	228	221	231	2.01e-34	121
ShaoY_2019_ERR3405992_bin.9_k141_1737_39	NCBI|WP_063856716.1|1|1|vanR-A|vanR-A|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-A|AMR|glycopeptide	32.9	228	221	231	2.01e-34	121
ShaoY_2019_ERR3405992_bin.9_k141_1737_39	NCBI|WP_063856718.1|1|1|vanR-E|vanR-E|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-E|AMR|glycopeptide	33.0	230	221	229	7.53e-34	120
ShaoY_2019_ERR3405992_bin.9_k141_1737_39	NCBI|WP_001280781.1|1|1|vanR-A|vanR-A|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-A|AMR|glycopeptide	32.2	227	221	231	2.21e-33	119
ShaoY_2019_ERR3405992_bin.9_k141_1737_39	NCBI|WP_063856720.1|1|1|vanR-A|vanR-A|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-A|AMR|glycopeptide	31.7	227	221	231	4.37e-33	118
ShaoY_2019_ERR3405992_bin.9_k141_1737_39	NCBI|WP_011461303.1|1|1|vanR-I|vanR-I|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-I|AMR|glycopeptide	31.0	229	221	232	1.36e-31	114
ShaoY_2019_ERR3405992_bin.9_k141_1737_39	megares|MEG_7482|Drugs|Glycopeptide|VanL-type_regulator|VANRI_1	31.0	229	221	232	1.36e-31	114
ShaoY_2019_ERR3405992_bin.9_k141_1737_39	megares|MEG_4078|Drugs|Multi-drug_resistance|Multi-drug_RND_efflux_regulator|MTRAD_1	31.2	221	221	228	4.35e-28	105
ShaoY_2019_ERR3405992_bin.9_k141_1737_62	SARG|gb|ANZ79476.1|ARO:3003908|Erm(47)	33.9	186	289	246	2.68e-24	97.4
ShaoY_2019_ERR3405992_bin.9_k141_1737_62	SARG|gb|CZT31773.1|ARO:3004094|Erm(48)	33.8	219	289	243	9.45e-23	93.2
ShaoY_2019_ERR3405992_bin.9_k141_1737_62	SARG|BAD86539	29.3	215	289	244	1.34e-22	92.8
ShaoY_2019_ERR3405992_bin.9_k141_1737_62	SARG|L22689.1.gene1.p01	30.2	242	289	257	8.54e-21	88.2
ShaoY_2019_ERR3405992_bin.9_k141_1737_62	SARG|gb|CBY77552.1|ARO:3003106|Erm(42)	34.0	159	289	301	4.17e-16	75.9
ShaoY_2019_ERR3405992_bin.9_k141_1737_62	NCBI|WP_052259183.1|1|1|erm(42)|erm(42)|target_modification|2|CLINDAMYCIN/ERYTHROMYCIN|LINCOSAMIDE/MACROLIDE|23S_rRNA_(adenine(2058)-N(6))-methyltransferase_Erm(42)|AMR|multidrug	33.3	159	289	301	5.70e-16	75.5
ShaoY_2019_ERR3405992_bin.9_k141_1737_62	megares|MEG_2781|Drugs|MLS|23S_rRNA_methyltransferases|ERM42_1	33.3	159	289	303	5.81e-16	75.5
ShaoY_2019_ERR3405992_bin.9_k141_1737_62	SARG|gb|OPG86592.1|ARO:3004626|Erm(49)	28.5	214	289	304	3.77e-15	73.2
ShaoY_2019_ERR3405992_bin.9_k141_1737_81	SARG|gi|1033151784|ref|WP_064457526.1|	27.7	202	258	614	7.40e-15	72.8
ShaoY_2019_ERR3405992_bin.9_k141_1737_81	SARG|gi|987887954|ref|WP_060953374.1|	27.7	202	258	614	7.40e-15	72.8
ShaoY_2019_ERR3405992_bin.9_k141_1737_81	SARG|gi|664304639|ref|WP_030834011.1|	27.7	202	258	614	7.40e-15	72.8
ShaoY_2019_ERR3405992_bin.9_k141_1737_81	SARG|gi|1011069317|ref|WP_062010695.1|	27.7	202	258	614	7.40e-15	72.8
ShaoY_2019_ERR3405992_bin.9_k141_1737_81	SARG|gb|WP_104671188.1|ARO:3003948|efrA	23.8	227	258	575	9.72e-15	72.4
ShaoY_2019_ERR3405992_bin.9_k141_1737_81	SARG|gi|827013130|ref|WP_047175495.1|	27.1	207	258	603	1.34e-14	72.0
ShaoY_2019_ERR3405992_bin.9_k141_1737_81	SARG|gi|517787730|ref|WP_018957938.1|	26.6	207	258	610	1.81e-14	71.6
ShaoY_2019_ERR3405992_bin.9_k141_1737_81	SARG|gi|664170108|ref|WP_030704355.1|	26.2	202	258	603	2.43e-14	71.2
ShaoY_2019_ERR3405992_bin.9_k141_1737_81	SARG|gi|501350226|ref|WP_012381861.1|	26.2	202	258	603	2.43e-14	71.2
ShaoY_2019_ERR3405992_bin.9_k141_1737_81	SARG|gi|695891735|ref|WP_032792824.1|	26.6	207	258	603	2.43e-14	71.2
ShaoY_2019_ERR3405992_bin.9_k141_1737_88	NCBI|WP_002389535.1|1|1|bcrA_Lm|bcrA_Lm||2|peptide|peptide|peptide_resistance_ABC_transporter_ATP-binding_subunit_BcrA|AMR|peptide	37.2	226	221	307	2.19e-38	134
ShaoY_2019_ERR3405992_bin.9_k141_1737_88	SARG|gi|507044560|ref|WP_016115614.1|	35.1	211	221	306	4.23e-38	133
ShaoY_2019_ERR3405992_bin.9_k141_1737_88	SARG|gi|446026113|ref|WP_000103968.1|	34.6	211	221	306	3.26e-37	130
ShaoY_2019_ERR3405992_bin.9_k141_1737_88	SARG|P42332	35.1	211	221	306	4.93e-36	127
ShaoY_2019_ERR3405992_bin.9_k141_1737_88	megares|MEG_1213|Drugs|Bacitracin|Bacitracin_ABC_transporter|BCRA_1	35.1	211	221	306	4.93e-36	127
ShaoY_2019_ERR3405992_bin.9_k141_1737_88	SARG|gi|510143239|gb|AGN36970.1|	35.1	211	221	313	5.72e-36	127
ShaoY_2019_ERR3405992_bin.9_k141_1737_88	SARG|AAD21213	35.1	211	221	306	1.91e-35	126
ShaoY_2019_ERR3405992_bin.9_k141_1737_88	SARG|ABB80128	34.6	211	221	306	2.69e-35	125
ShaoY_2019_ERR3405992_bin.9_k141_1737_88	SARG|gi|500194536|ref|WP_011867743.1|	34.9	218	221	306	3.77e-35	125
ShaoY_2019_ERR3405992_bin.9_k141_1737_88	SARG|gi|507035724|ref|WP_016107411.1|	34.1	211	221	309	4.01e-35	125
ShaoY_2019_ERR3405992_bin.9_k141_1737_107	SARG|gi|803568669|ref|WP_046077412.1|	28.7	237	265	648	3.16e-19	85.9
ShaoY_2019_ERR3405992_bin.9_k141_1737_107	SARG|gi|446110352|ref|WP_000188207.1|	28.7	237	265	648	3.16e-19	85.9
ShaoY_2019_ERR3405992_bin.9_k141_1737_107	SARG|YP_002382193	28.7	237	265	648	3.16e-19	85.9
ShaoY_2019_ERR3405992_bin.9_k141_1737_107	SARG|gi|803575554|ref|WP_046081557.1|	28.7	237	265	648	3.16e-19	85.9
ShaoY_2019_ERR3405992_bin.9_k141_1737_107	SARG|gi|446110351|ref|WP_000188206.1|	28.7	237	265	648	3.16e-19	85.9
ShaoY_2019_ERR3405992_bin.9_k141_1737_107	SARG|gi|1035706844|ref|WP_064548272.1|	29.1	237	265	648	7.81e-19	84.7
ShaoY_2019_ERR3405992_bin.9_k141_1737_107	SARG|gi|1035670474|ref|WP_064517458.1|	28.3	237	265	648	1.06e-18	84.3
ShaoY_2019_ERR3405992_bin.9_k141_1737_107	SARG|gi|1035717981|ref|WP_064557480.1|	28.3	237	265	648	1.06e-18	84.3
ShaoY_2019_ERR3405992_bin.9_k141_1737_107	SARG|gi|736472622|ref|WP_034494292.1|	28.3	237	265	648	1.93e-18	83.6
ShaoY_2019_ERR3405992_bin.9_k141_1737_107	SARG|gi|502669352|ref|WP_012905216.1|	27.4	237	265	648	3.52e-18	82.8
ShaoY_2019_ERR3405992_bin.9_k141_1737_134	SARG|gi|754724054|ref|WP_042095806.1|	39.6	230	239	648	8.74e-53	179
ShaoY_2019_ERR3405992_bin.9_k141_1737_134	SARG|gi|693238509|ref|WP_032348033.1|	39.6	230	239	648	8.74e-53	179
ShaoY_2019_ERR3405992_bin.9_k141_1737_134	SARG|gi|485870849|ref|WP_001467831.1|	39.6	230	239	648	8.74e-53	179
ShaoY_2019_ERR3405992_bin.9_k141_1737_134	SARG|gi|979505419|ref|WP_059334195.1|	39.6	230	239	648	1.22e-52	179
ShaoY_2019_ERR3405992_bin.9_k141_1737_134	SARG|ZP_04001960	39.6	230	239	648	1.22e-52	179
ShaoY_2019_ERR3405992_bin.9_k141_1737_134	SARG|gi|545164255|ref|WP_021518974.1|	39.6	230	239	648	1.22e-52	179
ShaoY_2019_ERR3405992_bin.9_k141_1737_134	SARG|gi|979422229|ref|WP_059319814.1|	39.6	230	239	648	1.22e-52	179
ShaoY_2019_ERR3405992_bin.9_k141_1737_134	SARG|gi|1001782895|ref|WP_061321573.1|	39.6	230	239	648	1.22e-52	179
ShaoY_2019_ERR3405992_bin.9_k141_1737_134	SARG|gi|754731641|ref|WP_042100724.1|	39.6	230	239	648	1.22e-52	179
ShaoY_2019_ERR3405992_bin.9_k141_1737_134	SARG|gi|754637749|ref|WP_042024023.1|	39.6	230	239	648	1.22e-52	179
ShaoY_2019_ERR3405992_bin.9_k141_3958_21	CARD|gb|AAA99503.1|ARO:3003250|bcrC	35.0	103	171	203	1.40e-11	59.3
ShaoY_2019_ERR3405992_bin.9_k141_4215_24	NCBI|WP_002389535.1|1|1|bcrA_Lm|bcrA_Lm||2|peptide|peptide|peptide_resistance_ABC_transporter_ATP-binding_subunit_BcrA|AMR|peptide	23.7	236	256	307	1.11e-14	71.2
ShaoY_2019_ERR3405992_bin.9_k141_4215_24	SARG|gb|QHW12375.1|ARO:3005087|msrF	28.7	230	256	486	1.57e-14	71.6
ShaoY_2019_ERR3405992_bin.9_k141_4215_24	NCBI|WP_000052512.1|1|1|msr(E)|msr(E)|target_protection|2|AZITHROMYCIN/ERYTHROMYCIN/STREPTOGRAMIN|MACROLIDE/STREPTOGRAMIN|ABC-F_type_ribosomal_protection_protein_Msr(E)|AMR|multidrug	29.4	204	256	491	5.23e-14	70.1
ShaoY_2019_ERR3405992_bin.9_k141_4215_24	SARG|gb|QQA64075.1|ARO:3007043|msr(I)	27.0	230	256	485	7.01e-14	69.7
ShaoY_2019_ERR3405992_bin.9_k141_4215_24	SARG|QHW12308.1	28.3	230	256	486	3.13e-13	67.8
ShaoY_2019_ERR3405992_bin.9_k141_4215_24	SARG|DAC81085.1	26.8	231	256	486	4.22e-13	67.4
ShaoY_2019_ERR3405992_bin.9_k141_4215_24	SARG|gb|QNR09092.1|ARO:3007042|msr(G)	29.4	194	256	485	1.50e-11	62.8
ShaoY_2019_ERR3405992_bin.9_k141_4215_24	SARG|U82085.gene.p01	27.6	192	256	552	3.88e-11	61.6
ShaoY_2019_ERR3405992_bin.9_k141_4215_38	SARG|gb|AET10444.1|ARO:3004032|tetA(46)	28.1	263	331	574	1.05e-17	82.8
ShaoY_2019_ERR3405992_bin.9_k141_4215_38	NCBI|AJP12342.1|1|1|cplR|cplR|target_protection|1|CLINDAMYCIN/LINCOMYCIN/RETAPAMULIN/VIRGINIAMYCIN|LINCOSAMIDE/PLEUROMUTILIN/STREPTOGRAMIN|ABC-F_type_ribosomal_protection_protein_CplR|AMR|multidrug	25.7	222	331	550	7.20e-11	62.0
ShaoY_2019_ERR3405992_bin.9_k141_4215_38	SARG|gb|SOX29786.1|ARO:3004730|tva(A)	23.3	189	331	505	8.93e-08	52.4
ShaoY_2019_ERR3405992_bin.9_k141_4215_38	NCBI|WP_014936356.1|1|1|tva(B)|tva(B)|target_protection|2|TIAMULIN|PLEUROMUTILIN|ABC-F_type_ribosomal_protection_protein_Tva(B)|AMR|pleuromutilin	24.7	190	331	504	1.16e-06	48.9
ShaoY_2019_ERR3405992_bin.9_k141_4215_38	NCBI|AKC61310.1|1|1|cplR|cplR|target_protection|1|CLINDAMYCIN/LINCOMYCIN/RETAPAMULIN/VIRGINIAMYCIN|LINCOSAMIDE/PLEUROMUTILIN/STREPTOGRAMIN|ABC-F_type_ribosomal_protection_protein_CplR|AMR|multidrug	19.5	200	331	552	8.73e-06	46.2
ShaoY_2019_ERR3405992_bin.9_k141_4215_39	NCBI|XSG12260.1|1|1|drcA|drcA||1|||daptomycin_efflux_ABC_transporter_ATP-binding_protein_DrcA|AMR|peptide	30.2	235	335	255	2.05e-25	101
ShaoY_2019_ERR3405992_bin.9_k141_4215_39	SARG|Q83LR7	32.2	230	335	648	4.60e-23	99.0
ShaoY_2019_ERR3405992_bin.9_k141_4215_39	SARG|gi|647325472|ref|WP_025760953.1|	32.2	230	335	648	4.60e-23	99.0
ShaoY_2019_ERR3405992_bin.9_k141_4215_39	SARG|gi|647323678|ref|WP_025760497.1|	32.2	230	335	648	4.60e-23	99.0
ShaoY_2019_ERR3405992_bin.9_k141_4215_39	SARG|gi|974672242|ref|WP_059256507.1|	32.5	231	335	648	1.13e-22	97.8
ShaoY_2019_ERR3405992_bin.9_k141_4215_39	SARG|gi|974641719|ref|WP_059227752.1|	32.5	231	335	648	1.13e-22	97.8
ShaoY_2019_ERR3405992_bin.9_k141_4215_39	SARG|gi|643601187|ref|WP_025237288.1|	32.5	231	335	648	1.13e-22	97.8
ShaoY_2019_ERR3405992_bin.9_k141_4215_39	SARG|gi|974628291|ref|WP_059215695.1|	32.5	231	335	648	1.13e-22	97.8
ShaoY_2019_ERR3405992_bin.9_k141_4215_39	SARG|gi|446110298|ref|WP_000188153.1|	32.5	231	335	648	1.13e-22	97.8
ShaoY_2019_ERR3405992_bin.9_k141_4215_39	SARG|gi|446110299|ref|WP_000188154.1|	32.5	231	335	648	1.13e-22	97.8
ShaoY_2019_ERR3405992_bin.9_k141_4215_44	NCBI|AXB64455.1|1|1|vanS-Cd|vanS-Cd|re-structuring_of_the_cell_wall|1|VANCOMYCIN|GLYCOPEPTIDE|VanG-Cd-type_glycopeptide_resistance_histidine_kinase_VanS|AMR|glycopeptide	26.6	286	316	380	3.32e-27	108
ShaoY_2019_ERR3405992_bin.9_k141_4215_44	megares|MEG_7498|Drugs|Glycopeptide|VanC-type_regulator|VANSC_1	26.6	286	316	380	3.32e-27	108
ShaoY_2019_ERR3405992_bin.9_k141_4215_44	NCBI|WP_023042297.1|1|1|vanS-D|vanS-D|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_histidine_kinase_VanS-D|AMR|glycopeptide	28.8	278	316	381	8.83e-27	107
ShaoY_2019_ERR3405992_bin.9_k141_4215_44	megares|MEG_7509|Drugs|Glycopeptide|VanD-type_regulator|VANSD_1	28.8	278	316	381	8.83e-27	107
ShaoY_2019_ERR3405992_bin.9_k141_4215_44	megares|MEG_7507|Drugs|Glycopeptide|VanD-type_regulator|VANSD_1	28.4	278	316	381	2.98e-25	103
ShaoY_2019_ERR3405992_bin.9_k141_4215_44	NCBI|WP_063856738.1|1|1|vanS-D|vanS-D|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_histidine_kinase_VanS-D|AMR|glycopeptide	28.4	278	316	381	2.98e-25	103
ShaoY_2019_ERR3405992_bin.9_k141_4215_44	megares|MEG_7505|Drugs|Glycopeptide|VanD-type_regulator|VANSD_1	27.7	278	316	381	2.76e-24	100
ShaoY_2019_ERR3405992_bin.9_k141_4215_44	NCBI|WP_063856730.1|1|1|vanS-D|vanS-D|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_histidine_kinase_VanS-D|AMR|glycopeptide	27.7	278	316	381	2.76e-24	100
ShaoY_2019_ERR3405992_bin.9_k141_4215_44	megares|MEG_7500|Drugs|Glycopeptide|VanC-type_regulator|VANSC_1	28.0	268	316	352	5.07e-24	99.4
ShaoY_2019_ERR3405992_bin.9_k141_4215_44	NCBI|WP_028530133.1|1|1|vanS-D|vanS-D|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_histidine_kinase_VanS-D|AMR|glycopeptide	27.3	278	316	381	9.80e-24	99.0
ShaoY_2019_ERR3405992_bin.9_k141_4215_46	NCBI|WP_002389535.1|1|1|bcrA_Lm|bcrA_Lm||2|peptide|peptide|peptide_resistance_ABC_transporter_ATP-binding_subunit_BcrA|AMR|peptide	45.2	303	306	307	2.23e-87	263
ShaoY_2019_ERR3405992_bin.9_k141_4215_46	SARG|ABB80128	44.2	301	306	306	9.11e-84	253
ShaoY_2019_ERR3405992_bin.9_k141_4215_46	SARG|P42332	43.9	301	306	306	2.58e-83	252
ShaoY_2019_ERR3405992_bin.9_k141_4215_46	megares|MEG_1213|Drugs|Bacitracin|Bacitracin_ABC_transporter|BCRA_1	43.9	301	306	306	2.58e-83	252
ShaoY_2019_ERR3405992_bin.9_k141_4215_46	SARG|gi|510143239|gb|AGN36970.1|	43.9	301	306	313	3.22e-83	252
ShaoY_2019_ERR3405992_bin.9_k141_4215_46	SARG|gi|542061059|gb|ERI11611.1|	43.4	302	306	316	3.53e-83	252
ShaoY_2019_ERR3405992_bin.9_k141_4215_46	SARG|AAD21213	43.5	301	306	306	7.33e-83	251
ShaoY_2019_ERR3405992_bin.9_k141_4215_46	SARG|gi|447195835|ref|WP_001273091.1|	44.5	301	306	306	1.47e-82	250
ShaoY_2019_ERR3405992_bin.9_k141_4215_46	SARG|gi|447195836|ref|WP_001273092.1|	44.2	301	306	306	4.17e-82	249
ShaoY_2019_ERR3405992_bin.9_k141_4215_46	SARG|gi|445996732|ref|WP_000074587.1|	43.5	301	306	309	6.47e-82	249
ShaoY_2019_ERR3405992_bin.9_k141_4215_47	NCBI|WP_063856728.1|1|1|vanR-N|vanR-N|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-N|AMR|glycopeptide	39.0	251	262	230	2.64e-40	138
ShaoY_2019_ERR3405992_bin.9_k141_4215_47	NCBI|WP_063856724.1|1|1|vanR-L|vanR-L|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-L|AMR|glycopeptide	34.3	251	262	231	1.98e-36	128
ShaoY_2019_ERR3405992_bin.9_k141_4215_47	NCBI|WP_063856718.1|1|1|vanR-E|vanR-E|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-E|AMR|glycopeptide	35.2	256	262	229	1.46e-35	125
ShaoY_2019_ERR3405992_bin.9_k141_4215_47	NCBI|WP_006285581.1|1|1|vanR-F|vanR-F|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-F|AMR|glycopeptide	34.5	252	262	231	5.99e-35	124
ShaoY_2019_ERR3405992_bin.9_k141_4215_47	NCBI|WP_005228837.1|1|1|vanR-C|vanR-C|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-C|AMR|glycopeptide	35.4	254	262	231	8.42e-35	124
ShaoY_2019_ERR3405992_bin.9_k141_4215_47	NCBI|WP_003126775.1|1|1|vanR-C|vanR-C|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-C|AMR|glycopeptide	34.7	251	262	231	1.18e-34	123
ShaoY_2019_ERR3405992_bin.9_k141_4215_47	NCBI|WP_034872470.1|1|1|vanR-C|vanR-C|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-C|AMR|glycopeptide	35.4	254	262	231	1.66e-34	123
ShaoY_2019_ERR3405992_bin.9_k141_4215_47	NCBI|WP_222891057.1|1|1|vanR-P|vanR-P|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-P|AMR|glycopeptide	34.7	259	262	239	2.03e-34	123
ShaoY_2019_ERR3405992_bin.9_k141_4215_47	NCBI|WP_063856725.1|1|1|vanR-C|vanR-C|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-C|AMR|glycopeptide	35.4	254	262	231	3.29e-34	122
ShaoY_2019_ERR3405992_bin.9_k141_4215_47	NCBI|WP_021418928.1|1|1|vanR-G|vanR-G|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-G|AMR|glycopeptide	33.3	255	262	235	1.01e-33	121
ShaoY_2019_ERR3405992_bin.9_k141_5764_5	CARD|gb|ATC67679.1|ARO:3000838|arlR	25.0	112	535	219	1.26e-06	48.5
ShaoY_2019_ERR3405992_bin.9_k141_5764_5	megares|MEG_4078|Drugs|Multi-drug_resistance|Multi-drug_RND_efflux_regulator|MTRAD_1	24.4	123	535	228	1.85e-06	48.1
ShaoY_2019_ERR3405992_bin.9_k141_5764_7	SARG|gi|542061059|gb|ERI11611.1|	25.0	268	503	316	1.81e-19	88.2
ShaoY_2019_ERR3405992_bin.9_k141_5764_7	SARG|P42332	24.7	219	503	306	1.74e-18	85.1
ShaoY_2019_ERR3405992_bin.9_k141_5764_7	megares|MEG_1213|Drugs|Bacitracin|Bacitracin_ABC_transporter|BCRA_1	24.7	219	503	306	1.74e-18	85.1
ShaoY_2019_ERR3405992_bin.9_k141_5764_7	SARG|gi|510143239|gb|AGN36970.1|	24.7	219	503	313	1.91e-18	85.1
ShaoY_2019_ERR3405992_bin.9_k141_5764_7	SARG|YP_001373621	24.5	274	503	318	2.04e-18	85.1
ShaoY_2019_ERR3405992_bin.9_k141_5764_7	SARG|ABB80128	24.7	219	503	306	2.35e-18	84.7
ShaoY_2019_ERR3405992_bin.9_k141_5764_7	SARG|AAD21213	24.7	219	503	306	5.78e-18	83.6
ShaoY_2019_ERR3405992_bin.9_k141_5764_7	SARG|gi|695701476|ref|WP_032638992.1|	26.3	247	503	646	2.28e-15	77.8
ShaoY_2019_ERR3405992_bin.9_k141_5764_7	SARG|gb|AYV52072.1|ARO:3002882|lmrD	27.9	233	503	664	2.21e-14	74.7
ShaoY_2019_ERR3405992_bin.9_k141_5764_7	SARG|gb|CDO61516.1|ARO:3003949|efrB	25.0	184	503	362	1.24e-11	65.1
ShaoY_2019_ERR3405992_bin.9_k141_6776_19	CARD|gb|AAD51347.1|ARO:3003067|smeS	29.2	277	480	467	2.71e-38	144
ShaoY_2019_ERR3405992_bin.9_k141_6776_19	NCBI|WP_063856744.1|1|1|vanS-D|vanS-D|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_histidine_kinase_VanS-D|AMR|glycopeptide	31.9	248	480	381	2.31e-33	129
ShaoY_2019_ERR3405992_bin.9_k141_6776_19	megares|MEG_7504|Drugs|Glycopeptide|VanD-type_regulator|VANSD_1	31.9	248	480	381	2.31e-33	129
ShaoY_2019_ERR3405992_bin.9_k141_6776_19	megares|MEG_7505|Drugs|Glycopeptide|VanD-type_regulator|VANSD_1	29.6	250	480	381	9.49e-31	121
ShaoY_2019_ERR3405992_bin.9_k141_6776_19	NCBI|WP_063856730.1|1|1|vanS-D|vanS-D|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_histidine_kinase_VanS-D|AMR|glycopeptide	29.6	250	480	381	9.49e-31	121
ShaoY_2019_ERR3405992_bin.9_k141_6776_19	megares|MEG_7507|Drugs|Glycopeptide|VanD-type_regulator|VANSD_1	29.7	246	480	381	2.44e-30	120
ShaoY_2019_ERR3405992_bin.9_k141_6776_19	NCBI|WP_063856738.1|1|1|vanS-D|vanS-D|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_histidine_kinase_VanS-D|AMR|glycopeptide	29.7	246	480	381	2.44e-30	120
ShaoY_2019_ERR3405992_bin.9_k141_6776_19	NCBI|WP_028530133.1|1|1|vanS-D|vanS-D|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_histidine_kinase_VanS-D|AMR|glycopeptide	29.2	250	480	381	1.17e-29	118
ShaoY_2019_ERR3405992_bin.9_k141_6776_19	megares|MEG_7506|Drugs|Glycopeptide|VanD-type_regulator|VANSD_1	29.2	250	480	381	1.17e-29	118
ShaoY_2019_ERR3405992_bin.9_k141_6776_19	NCBI|WP_023042297.1|1|1|vanS-D|vanS-D|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_histidine_kinase_VanS-D|AMR|glycopeptide	29.3	246	480	381	2.99e-29	117
ShaoY_2019_ERR3405992_bin.9_k141_6776_20	megares|MEG_4078|Drugs|Multi-drug_resistance|Multi-drug_RND_efflux_regulator|MTRAD_1	48.0	229	234	228	1.39e-71	217
ShaoY_2019_ERR3405992_bin.9_k141_6776_20	NCBI|WP_006285581.1|1|1|vanR-F|vanR-F|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-F|AMR|glycopeptide	43.6	227	234	231	2.95e-61	191
ShaoY_2019_ERR3405992_bin.9_k141_6776_20	NCBI|WP_011461303.1|1|1|vanR-I|vanR-I|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-I|AMR|glycopeptide	42.2	232	234	232	7.91e-59	184
ShaoY_2019_ERR3405992_bin.9_k141_6776_20	megares|MEG_7482|Drugs|Glycopeptide|VanL-type_regulator|VANRI_1	42.2	232	234	232	7.91e-59	184
ShaoY_2019_ERR3405992_bin.9_k141_6776_20	CARD|gb|ATC67679.1|ARO:3000838|arlR	43.1	225	234	219	2.14e-58	183
ShaoY_2019_ERR3405992_bin.9_k141_6776_20	NCBI|WP_063856726.1|1|1|vanR-M|vanR-M|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-M|AMR|glycopeptide	42.7	227	234	232	1.80e-57	181
ShaoY_2019_ERR3405992_bin.9_k141_6776_20	CARD|gb|AAD51348.1|ARO:3003066|smeR	43.0	235	234	229	3.30e-57	180
ShaoY_2019_ERR3405992_bin.9_k141_6776_20	NCBI|WP_021418928.1|1|1|vanR-G|vanR-G|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-G|AMR|glycopeptide	40.4	235	234	235	7.91e-57	179
ShaoY_2019_ERR3405992_bin.9_k141_6776_20	NCBI|AXB64454.1|1|1|vanR-Cd|vanR-Cd|re-structuring_of_the_cell_wall|1|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-G-Cd|AMR|glycopeptide	41.6	233	234	233	1.05e-56	179
ShaoY_2019_ERR3405992_bin.9_k141_6776_20	NCBI|WP_063856727.1|1|1|vanR-D|vanR-D|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-D|AMR|glycopeptide	38.9	234	234	232	4.66e-55	175
ShaoY_2019_ERR3405992_bin.9_k141_8490_20	SARG|gi|500194536|ref|WP_011867743.1|	39.9	208	209	306	1.04e-38	134
ShaoY_2019_ERR3405992_bin.9_k141_8490_20	SARG|gi|500465078|gb|EOP76697.1|	41.7	192	209	306	4.06e-38	132
ShaoY_2019_ERR3405992_bin.9_k141_8490_20	SARG|gi|500448961|gb|EOP61695.1|	41.7	192	209	306	5.71e-38	132
ShaoY_2019_ERR3405992_bin.9_k141_8490_20	SARG|gi|507050365|ref|WP_016121371.1|	39.6	207	209	309	2.38e-37	130
ShaoY_2019_ERR3405992_bin.9_k141_8490_20	SARG|gi|542061059|gb|ERI11611.1|	38.0	208	209	316	2.77e-37	130
ShaoY_2019_ERR3405992_bin.9_k141_8490_20	SARG|gi|447195835|ref|WP_001273091.1|	40.9	193	209	306	3.13e-37	130
ShaoY_2019_ERR3405992_bin.9_k141_8490_20	SARG|gi|507044560|ref|WP_016115614.1|	40.6	192	209	306	3.13e-37	130
ShaoY_2019_ERR3405992_bin.9_k141_8490_20	SARG|ZP_04081918	40.4	193	209	306	4.40e-37	130
ShaoY_2019_ERR3405992_bin.9_k141_8490_20	SARG|gi|445996719|ref|WP_000074574.1|	39.6	207	209	309	4.70e-37	130
ShaoY_2019_ERR3405992_bin.9_k141_8490_20	SARG|gi|488130770|ref|WP_002201978.1|	42.2	192	209	309	4.70e-37	130
ShaoY_2019_ERR3405992_bin.9_k141_8490_25	NCBI|WP_002389535.1|1|1|bcrA_Lm|bcrA_Lm||2|peptide|peptide|peptide_resistance_ABC_transporter_ATP-binding_subunit_BcrA|AMR|peptide	39.4	208	211	307	4.82e-48	158
ShaoY_2019_ERR3405992_bin.9_k141_8490_25	SARG|gi|500448961|gb|EOP61695.1|	37.0	208	211	306	4.30e-42	143
ShaoY_2019_ERR3405992_bin.9_k141_8490_25	SARG|gi|500465078|gb|EOP76697.1|	37.0	208	211	306	1.20e-41	142
ShaoY_2019_ERR3405992_bin.9_k141_8490_25	SARG|gi|447195835|ref|WP_001273091.1|	37.9	211	211	306	2.38e-41	141
ShaoY_2019_ERR3405992_bin.9_k141_8490_25	SARG|ZP_04081918	37.4	211	211	306	6.62e-41	140
ShaoY_2019_ERR3405992_bin.9_k141_8490_25	SARG|gi|447195836|ref|WP_001273092.1|	37.4	211	211	306	6.62e-41	140
ShaoY_2019_ERR3405992_bin.9_k141_8490_25	SARG|gi|445996719|ref|WP_000074574.1|	36.1	208	211	309	1.98e-40	139
ShaoY_2019_ERR3405992_bin.9_k141_8490_25	SARG|gi|445996722|ref|WP_000074577.1|	36.5	208	211	309	1.98e-40	139
ShaoY_2019_ERR3405992_bin.9_k141_8490_25	SARG|gi|445996723|ref|WP_000074578.1|	36.1	208	211	309	2.78e-40	138
ShaoY_2019_ERR3405992_bin.9_k141_8490_25	SARG|gi|895808656|emb|COR83787.1|	35.6	208	211	309	3.92e-40	138
ShaoY_2019_ERR3405992_bin.9_k141_10290_1	CARD|gb|ABU39979.1|ARO:3000217|blaR1	43.6	367	387	588	6.24e-101	310
ShaoY_2019_ERR3405992_bin.9_k141_10290_1	NCBI|WP_012705551.1|1|1|blaR1_gen|blaR1_gen|regulation|2|beta-lactam|beta-lactam|BlaR1_family_beta-lactam_sensor/signal_transducer|AMR|beta-lactam	39.4	388	387	593	1.22e-91	286
ShaoY_2019_ERR3405992_bin.9_k141_10290_1	megares|MEG_3786|Drugs|beta-lactam|Penicillin_binding_protein|MECA_1	35.8	385	387	585	4.19e-78	250
ShaoY_2019_ERR3405992_bin.9_k141_10290_1	NCBI|WP_000952923.1|1|1|mecR1|mecR1|regulation|2|METHICILLIN|beta-lactam|beta-lactam_sensor/signal_transducer_MecR1|AMR|beta-lactam	35.8	385	387	585	4.19e-78	250
ShaoY_2019_ERR3405992_bin.9_k141_10290_1	NCBI|WP_063842869.1|1|1|blaR1|blaR1|regulation|2|beta-lactam|beta-lactam|beta-lactam_sensor/signal_transducer_BlaR1|AMR|beta-lactam	33.9	387	387	585	1.43e-74	241
ShaoY_2019_ERR3405992_bin.9_k141_10290_1	NCBI|WP_001096376.1|1|1|blaR1|blaR1|regulation|2|beta-lactam|beta-lactam|beta-lactam_sensor/signal_transducer_BlaR1|AMR|beta-lactam	33.9	387	387	585	1.43e-74	241
ShaoY_2019_ERR3405992_bin.9_k141_10290_1	NCBI|WP_001096392.1|1|1|blaR1|blaR1|regulation|2|beta-lactam|beta-lactam|beta-lactam_sensor/signal_transducer_BlaR1|AMR|beta-lactam	33.9	387	387	585	2.01e-74	241
ShaoY_2019_ERR3405992_bin.9_k141_10290_1	NCBI|WP_001096386.1|1|1|blaR1-2|blaR1-2|regulation|2|beta-lactam|beta-lactam|beta-lactam_sensor/signal_transducer_BlaR1|AMR|beta-lactam	33.6	387	387	585	7.78e-74	239
ShaoY_2019_ERR3405992_bin.9_k141_10290_1	NCBI|WP_075071939.1|1|1|blaOXA-1089|blaOXA-1089_fam|hydrolase|2|CARBAPENEM|beta-lactam|carbapenem-hydrolyzing_class_D_beta-lactamase_OXA-1089|AMR|beta-lactam	40.1	232	387	289	4.99e-51	171
ShaoY_2019_ERR3405992_bin.9_k141_10290_1	SARG|gb|EIM09515.1|ARO:3004747|BAT-1	33.8	278	387	268	1.65e-49	167
ShaoY_2019_ERR3405992_bin.9_k141_10310_12	SARG|gi|498467693|ref|WP_010773049.1|	25.5	353	348	700	3.89e-21	93.6
ShaoY_2019_ERR3405992_bin.9_k141_10310_12	SARG|gb|ABX54689.1|ARO:3002973|vanTmL	22.7	309	348	329	6.05e-16	76.6
ShaoY_2019_ERR3405992_bin.9_k141_10310_12	megares|MEG_7535|Drugs|Glycopeptide|VanN-type_resistance_protein|VANTN_1	25.5	353	348	656	9.14e-14	71.2
ShaoY_2019_ERR3405992_bin.9_k141_10310_12	SARG|JF802084.2.gene3.p01	25.5	353	348	700	9.43e-14	71.2
ShaoY_2019_ERR3405992_bin.9_k141_10310_17	SARG|gb|AAC75314.1|ARO:3003578|pmrF	28.4	116	337	322	3.67e-07	50.1
ShaoY_2019_ERR3405992_bin.9_k141_10310_41	megares|MEG_7571|Drugs|Glycopeptide|VanM-type_resistance_protein|VANXM_2	36.8	459	465	451	7.80e-90	280
ShaoY_2019_ERR3405992_bin.9_k141_10310_41	megares|MEG_7572|Drugs|Glycopeptide|VanM-type_resistance_protein|VANXM_2	37.3	459	465	481	1.29e-89	280
ShaoY_2019_ERR3405992_bin.9_k141_10310_41	megares|MEG_7563|Drugs|Glycopeptide|VanB-type_resistance_protein|VANXB_2	36.8	457	465	451	6.76e-88	275
ShaoY_2019_ERR3405992_bin.9_k141_10310_42	NCBI|PBI24747.1|1|1|vanG-Cd|vanG-Cd|re-structuring_of_the_cell_wall|1|VANCOMYCIN|GLYCOPEPTIDE|D-alanine--D-serine_ligase_VanG-Cd|AMR|glycopeptide	30.1	365	352	366	4.13e-43	152
ShaoY_2019_ERR3405992_bin.9_k141_10310_45	megares|MEG_4308|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	46.8	679	681	655	1.88e-203	586
ShaoY_2019_ERR3405992_bin.9_k141_10310_45	megares|MEG_4318|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	46.7	679	681	655	1.51e-202	583
ShaoY_2019_ERR3405992_bin.9_k141_10310_45	megares|MEG_4316|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	46.7	679	681	655	1.51e-202	583
ShaoY_2019_ERR3405992_bin.9_k141_10310_45	megares|MEG_4307|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	46.7	679	681	655	3.03e-202	583
ShaoY_2019_ERR3405992_bin.9_k141_10310_45	megares|MEG_4313|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	46.5	679	681	655	1.72e-201	581
ShaoY_2019_ERR3405992_bin.9_k141_10310_45	megares|MEG_4309|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	46.5	679	681	655	2.44e-201	580
ShaoY_2019_ERR3405992_bin.9_k141_10310_45	megares|MEG_4312|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	46.5	679	681	655	2.44e-201	580
ShaoY_2019_ERR3405992_bin.9_k141_10310_45	megares|MEG_4311|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	46.5	679	681	655	2.44e-201	580
ShaoY_2019_ERR3405992_bin.9_k141_10310_45	megares|MEG_4315|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	46.5	679	681	655	2.44e-201	580
ShaoY_2019_ERR3405992_bin.9_k141_10310_45	megares|MEG_4305|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	46.5	679	681	655	2.44e-201	580
ShaoY_2019_ERR3405992_bin.9_k141_10310_47	CARD|gb|ABD30512.1|ARO:3000839|arlS	25.6	293	441	451	4.58e-29	117
ShaoY_2019_ERR3405992_bin.9_k141_10310_47	NCBI|WP_028530133.1|1|1|vanS-D|vanS-D|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_histidine_kinase_VanS-D|AMR|glycopeptide	31.0	216	441	381	2.81e-27	111
ShaoY_2019_ERR3405992_bin.9_k141_10310_47	megares|MEG_7506|Drugs|Glycopeptide|VanD-type_regulator|VANSD_1	31.0	216	441	381	2.81e-27	111
ShaoY_2019_ERR3405992_bin.9_k141_10310_47	NCBI|WP_023042297.1|1|1|vanS-D|vanS-D|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_histidine_kinase_VanS-D|AMR|glycopeptide	30.6	216	441	381	7.18e-27	110
ShaoY_2019_ERR3405992_bin.9_k141_10310_47	megares|MEG_7509|Drugs|Glycopeptide|VanD-type_regulator|VANSD_1	30.6	216	441	381	7.18e-27	110
ShaoY_2019_ERR3405992_bin.9_k141_10310_47	NCBI|WP_011461302.1|1|1|vanS-I|vanS-I|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_histidine_kinase_VanS-I|AMR|glycopeptide	24.8	327	441	392	1.55e-26	109
ShaoY_2019_ERR3405992_bin.9_k141_10310_47	NCBI|WP_006285582.1|1|1|vanS-F|vanS-F|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_histidine_kinase_VanS-F|AMR|glycopeptide	28.3	265	441	365	8.35e-25	103
ShaoY_2019_ERR3405992_bin.9_k141_10310_47	NCBI|WP_063856748.1|1|1|vanS-M|vanS-M|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_histidine_kinase_VanS-M|AMR|glycopeptide	27.2	254	441	370	3.07e-24	102
ShaoY_2019_ERR3405992_bin.9_k141_10310_47	NCBI|WP_002368696.1|1|1|vanS-B|vanS-B|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_histidine_kinase_VanS-B|AMR|glycopeptide	22.6	442	441	447	2.41e-17	82.8
ShaoY_2019_ERR3405992_bin.9_k141_10310_48	megares|MEG_4078|Drugs|Multi-drug_resistance|Multi-drug_RND_efflux_regulator|MTRAD_1	40.2	219	223	228	8.51e-49	158
ShaoY_2019_ERR3405992_bin.9_k141_10310_48	megares|MEG_7449|Drugs|Glycopeptide|VanA-type_regulator|VANRA_1	40.2	229	223	231	3.32e-46	152
ShaoY_2019_ERR3405992_bin.9_k141_10310_48	NCBI|WP_063856716.1|1|1|vanR-A|vanR-A|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-A|AMR|glycopeptide	40.2	229	223	231	3.32e-46	152
ShaoY_2019_ERR3405992_bin.9_k141_10310_48	NCBI|WP_063856720.1|1|1|vanR-A|vanR-A|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-A|AMR|glycopeptide	39.7	229	223	231	1.05e-44	148
ShaoY_2019_ERR3405992_bin.9_k141_10310_48	NCBI|WP_063856728.1|1|1|vanR-N|vanR-N|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-N|AMR|glycopeptide	37.5	232	223	230	3.62e-42	141
ShaoY_2019_ERR3405992_bin.9_k141_10310_48	NCBI|WP_063856726.1|1|1|vanR-M|vanR-M|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-M|AMR|glycopeptide	37.2	226	223	232	1.07e-41	140
ShaoY_2019_ERR3405992_bin.9_k141_10310_48	NCBI|WP_003126775.1|1|1|vanR-C|vanR-C|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-C|AMR|glycopeptide	34.9	229	223	231	1.83e-39	134
ShaoY_2019_ERR3405992_bin.9_k141_10310_48	NCBI|WP_006285581.1|1|1|vanR-F|vanR-F|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-F|AMR|glycopeptide	37.2	226	223	231	1.44e-38	132
ShaoY_2019_ERR3405992_bin.9_k141_10310_48	NCBI|WP_005228837.1|1|1|vanR-C|vanR-C|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-C|AMR|glycopeptide	34.1	229	223	231	2.87e-38	131
ShaoY_2019_ERR3405992_bin.9_k141_10310_48	NCBI|WP_063856725.1|1|1|vanR-C|vanR-C|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-C|AMR|glycopeptide	34.5	229	223	231	4.04e-38	131
ShaoY_2019_ERR3405992_bin.9_k141_10310_56	NCBI|WP_063856734.1|1|1|vanS-E|vanS-E|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_histidine_kinase_VanS-E|AMR|glycopeptide	30.5	262	801	357	2.04e-30	122
ShaoY_2019_ERR3405992_bin.9_k141_10310_56	megares|MEG_7511|Drugs|Glycopeptide|VanE-type_regulator|VANSE_1	30.5	262	801	357	2.04e-30	122
ShaoY_2019_ERR3405992_bin.9_k141_10310_56	NCBI|WP_006285582.1|1|1|vanS-F|vanS-F|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_histidine_kinase_VanS-F|AMR|glycopeptide	32.7	269	801	365	4.31e-30	121
ShaoY_2019_ERR3405992_bin.9_k141_10310_56	NCBI|WP_063856748.1|1|1|vanS-M|vanS-M|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_histidine_kinase_VanS-M|AMR|glycopeptide	29.8	275	801	370	2.11e-29	119
ShaoY_2019_ERR3405992_bin.9_k141_10310_56	NCBI|WP_028530133.1|1|1|vanS-D|vanS-D|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_histidine_kinase_VanS-D|AMR|glycopeptide	29.8	225	801	381	4.03e-23	101
ShaoY_2019_ERR3405992_bin.9_k141_10310_56	megares|MEG_7506|Drugs|Glycopeptide|VanD-type_regulator|VANSD_1	29.8	225	801	381	4.03e-23	101
ShaoY_2019_ERR3405992_bin.9_k141_10310_56	NCBI|WP_023042297.1|1|1|vanS-D|vanS-D|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_histidine_kinase_VanS-D|AMR|glycopeptide	28.5	242	801	381	9.76e-23	100
ShaoY_2019_ERR3405992_bin.9_k141_10310_56	megares|MEG_7505|Drugs|Glycopeptide|VanD-type_regulator|VANSD_1	28.9	242	801	381	9.76e-23	100
ShaoY_2019_ERR3405992_bin.9_k141_10310_56	megares|MEG_7509|Drugs|Glycopeptide|VanD-type_regulator|VANSD_1	28.5	242	801	381	9.76e-23	100
ShaoY_2019_ERR3405992_bin.9_k141_10310_56	NCBI|WP_063856730.1|1|1|vanS-D|vanS-D|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_histidine_kinase_VanS-D|AMR|glycopeptide	28.9	242	801	381	9.76e-23	100
ShaoY_2019_ERR3405992_bin.9_k141_10310_57	NCBI|WP_006285581.1|1|1|vanR-F|vanR-F|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-F|AMR|glycopeptide	42.9	226	230	231	7.90e-63	194
ShaoY_2019_ERR3405992_bin.9_k141_10310_57	NCBI|WP_063856726.1|1|1|vanR-M|vanR-M|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-M|AMR|glycopeptide	42.7	227	230	232	7.50e-61	189
ShaoY_2019_ERR3405992_bin.9_k141_10310_57	NCBI|WP_063856718.1|1|1|vanR-E|vanR-E|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-E|AMR|glycopeptide	40.4	228	230	229	3.89e-60	187
ShaoY_2019_ERR3405992_bin.9_k141_10310_57	NCBI|WP_011461303.1|1|1|vanR-I|vanR-I|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-I|AMR|glycopeptide	41.0	227	230	232	6.04e-60	187
ShaoY_2019_ERR3405992_bin.9_k141_10310_57	megares|MEG_7482|Drugs|Glycopeptide|VanL-type_regulator|VANRI_1	41.0	227	230	232	6.04e-60	187
ShaoY_2019_ERR3405992_bin.9_k141_10310_57	NCBI|WP_222891057.1|1|1|vanR-P|vanR-P|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-P|AMR|glycopeptide	40.0	230	230	239	2.12e-59	186
ShaoY_2019_ERR3405992_bin.9_k141_10310_57	NCBI|WP_021418928.1|1|1|vanR-G|vanR-G|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-G|AMR|glycopeptide	40.3	231	230	235	5.33e-59	185
ShaoY_2019_ERR3405992_bin.9_k141_10310_57	megares|MEG_7449|Drugs|Glycopeptide|VanA-type_regulator|VANRA_1	40.5	227	230	231	5.38e-58	182
ShaoY_2019_ERR3405992_bin.9_k141_10310_57	NCBI|WP_063856716.1|1|1|vanR-A|vanR-A|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-A|AMR|glycopeptide	40.5	227	230	231	5.38e-58	182
ShaoY_2019_ERR3405992_bin.9_k141_10310_57	NCBI|WP_063856721.1|1|1|vanR-A|vanR-A|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-A|AMR|glycopeptide	40.1	227	230	231	4.32e-57	180
ShaoY_2019_ERR3405992_bin.9_k141_10310_81	SARG|gb|WP_104671188.1|ARO:3003948|efrA	24.5	216	245	575	1.38e-14	71.6
ShaoY_2019_ERR3405992_bin.9_k141_10310_81	SARG|AXF35727.1	25.4	201	245	497	4.52e-10	58.2
ShaoY_2019_ERR3405992_bin.9_k141_10310_81	SARG|gi|727118387|ref|WP_033626720.1|	27.7	195	245	498	3.60e-09	55.5
ShaoY_2019_ERR3405992_bin.9_k141_10310_81	SARG|gi|488349878|ref|WP_002419263.1|	27.7	195	245	498	3.60e-09	55.5
ShaoY_2019_ERR3405992_bin.9_k141_10310_81	SARG|gi|498528849|ref|WP_010828356.1|	27.7	195	245	498	4.83e-09	55.1
ShaoY_2019_ERR3405992_bin.9_k141_10310_81	SARG|gi|881017353|ref|WP_048737885.1|	27.7	195	245	498	6.49e-09	54.7
ShaoY_2019_ERR3405992_bin.9_k141_10310_81	SARG|gi|514883218|ref|WP_016615053.1|	27.7	195	245	498	6.49e-09	54.7
ShaoY_2019_ERR3405992_bin.9_k141_10310_81	SARG|gi|488303094|ref|WP_002374069.1|	27.7	195	245	498	6.49e-09	54.7
ShaoY_2019_ERR3405992_bin.9_k141_10310_81	SARG|gi|488319039|ref|WP_002388424.1|	27.7	195	245	498	6.49e-09	54.7
ShaoY_2019_ERR3405992_bin.9_k141_10310_81	SARG|gi|498397181|ref|WP_010710665.1|	27.7	195	245	498	6.49e-09	54.7
ShaoY_2019_ERR3405992_bin.9_k141_11043_25	SARG|gb|APB03219.1|ARO:3003986|TaeA	48.9	657	634	648	3.57e-205	588
ShaoY_2019_ERR3405992_bin.9_k141_11043_25	megares|MEG_4318|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	31.2	536	634	655	2.18e-69	236
ShaoY_2019_ERR3405992_bin.9_k141_11043_25	megares|MEG_4308|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	31.2	536	634	655	2.18e-69	236
ShaoY_2019_ERR3405992_bin.9_k141_11043_25	megares|MEG_4306|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	31.0	536	634	655	1.56e-68	234
ShaoY_2019_ERR3405992_bin.9_k141_11043_25	megares|MEG_4313|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	31.0	536	634	655	3.01e-68	233
ShaoY_2019_ERR3405992_bin.9_k141_11043_25	megares|MEG_4307|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	31.0	536	634	655	3.01e-68	233
ShaoY_2019_ERR3405992_bin.9_k141_11043_25	megares|MEG_4312|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	31.0	536	634	655	3.01e-68	233
ShaoY_2019_ERR3405992_bin.9_k141_11043_25	megares|MEG_4316|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	31.0	536	634	655	3.01e-68	233
ShaoY_2019_ERR3405992_bin.9_k141_11043_25	megares|MEG_4315|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	31.0	536	634	655	3.01e-68	233
ShaoY_2019_ERR3405992_bin.9_k141_11043_25	megares|MEG_4309|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	31.0	536	634	655	4.17e-68	233
ShaoY_2019_ERR3405992_bin.9_k141_11043_33	NCBI|WP_000163435.1|1|1|mupA|mupA|insensitivity|2|mupirocin|mupirocin|mupirocin-resistant_isoleucine--tRNA_ligase_MupA|AMR|mupirocin	43.6	1042	1056	1024	2.52e-318	907
ShaoY_2019_ERR3405992_bin.9_k141_11043_33	megares|MEG_4089|Drugs|Mupirocin|Mupirocin-resistant_isoleucyl-tRNA_synthetase|MUPA_1	43.6	1042	1056	1024	2.52e-318	907
ShaoY_2019_ERR3405992_bin.9_k141_11043_33	megares|MEG_4091|Drugs|Mupirocin|Mupirocin-resistant_isoleucyl-tRNA_synthetase|MUPB_1	44.3	1006	1056	1033	1.78e-315	900
ShaoY_2019_ERR3405992_bin.9_k141_11043_33	SARG|gb|AEY83581|ARO:3000510|mupB	44.3	1006	1056	1033	1.78e-315	900
ShaoY_2019_ERR3405992_bin.9_k141_11043_33	megares|MEG_4090|Drugs|Mupirocin|Mupirocin-resistant_isoleucyl-tRNA_synthetase|MUPA_1	43.3	1042	1056	1024	1.86e-315	900
ShaoY_2019_ERR3405992_bin.9_k141_11043_33	SARG|gb|CAA53189|ARO:3000521|mupA	43.3	1042	1056	1024	1.86e-315	900
ShaoY_2019_ERR3405992_bin.9_k141_11043_33	megares|MEG_3295|Drugs|Mupirocin|Mupirocin-resistant_isoleucyl-tRNA_synthetase|ILES_1	36.2	1116	1056	1107	2.78e-217	650
ShaoY_2019_ERR3405992_bin.9_k141_11043_33	SARG|gb|ADP36409.1|ARO:3003730|Bifidobacteria	36.2	1116	1056	1107	2.78e-217	650
ShaoY_2019_ERR3405992_bin.9_k141_11043_38	NCBI|WP_063856718.1|1|1|vanR-E|vanR-E|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-E|AMR|glycopeptide	32.7	107	532	229	2.52e-10	59.7
ShaoY_2019_ERR3405992_bin.9_k141_11043_38	megares|MEG_4078|Drugs|Multi-drug_resistance|Multi-drug_RND_efflux_regulator|MTRAD_1	28.7	115	532	228	1.74e-07	51.2
ShaoY_2019_ERR3405992_bin.9_k141_11043_38	CARD|gb|ATC67679.1|ARO:3000838|arlR	26.0	131	532	219	2.12e-07	50.8
ShaoY_2019_ERR3405992_bin.9_k141_11043_38	CARD|gb|BAB36671.1|ARO:3000832|evgA	26.7	105	532	204	3.22e-07	50.1
ShaoY_2019_ERR3405992_bin.9_k141_11043_38	CARD|gb|ADM92605.1|ARO:3000553|adeR	24.8	133	532	247	9.28e-06	46.2
ShaoY_2019_ERR3405992_bin.9_k141_11433_12	SARG|gi|686113687|ref|WP_031764317.1|	25.2	266	456	451	2.74e-16	79.7
ShaoY_2019_ERR3405992_bin.9_k141_11446_8	NCBI|CCA59315.1|1|1|helR|helR||1|rifamycin|rifamycin|RNA_polymerase_recycling_motor_ATPase_HelR|AMR|rifamycin	25.6	195	1046	722	3.22e-15	79.3
ShaoY_2019_ERR3405992_bin.9_k141_11446_29	NCBI|WP_011461303.1|1|1|vanR-I|vanR-I|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-I|AMR|glycopeptide	31.0	229	230	232	6.35e-32	115
ShaoY_2019_ERR3405992_bin.9_k141_11446_29	megares|MEG_7482|Drugs|Glycopeptide|VanL-type_regulator|VANRI_1	31.0	229	230	232	6.35e-32	115
ShaoY_2019_ERR3405992_bin.9_k141_11446_29	NCBI|WP_063856723.1|1|1|vanR-B|vanR-B|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-B|AMR|glycopeptide	33.6	220	230	219	1.51e-29	108
ShaoY_2019_ERR3405992_bin.9_k141_11446_29	NCBI|WP_002317273.1|1|1|vanR-B|vanR-B|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-B|AMR|glycopeptide	33.6	220	230	219	2.13e-29	108
ShaoY_2019_ERR3405992_bin.9_k141_11446_29	NCBI|WP_063856719.1|1|1|vanR-B|vanR-B|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-B|AMR|glycopeptide	33.6	220	230	220	2.18e-29	108
ShaoY_2019_ERR3405992_bin.9_k141_11446_29	NCBI|WP_032489743.1|1|1|vanR-B|vanR-B|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-B|AMR|glycopeptide	33.6	220	230	220	3.06e-29	108
ShaoY_2019_ERR3405992_bin.9_k141_11446_29	NCBI|WP_021418928.1|1|1|vanR-G|vanR-G|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-G|AMR|glycopeptide	30.0	230	230	235	3.09e-29	108
ShaoY_2019_ERR3405992_bin.9_k141_11446_29	NCBI|WP_222891057.1|1|1|vanR-P|vanR-P|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-P|AMR|glycopeptide	30.0	233	230	239	9.36e-29	107
ShaoY_2019_ERR3405992_bin.9_k141_11446_29	NCBI|WP_002368697.1|1|1|vanR-B|vanR-B|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-B|AMR|glycopeptide	32.3	220	230	220	9.12e-28	104
ShaoY_2019_ERR3405992_bin.9_k141_11446_29	NCBI|AXB64454.1|1|1|vanR-Cd|vanR-Cd|re-structuring_of_the_cell_wall|1|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-G-Cd|AMR|glycopeptide	29.1	230	230	233	1.72e-27	103
ShaoY_2019_ERR3405992_bin.9_k141_11446_30	CARD|gb|CYF42523.1|ARO:3004047|kdpD	28.1	217	344	885	3.11e-14	72.8
ShaoY_2019_ERR3405992_bin.9_k141_11446_31	NCBI|XSG12260.1|1|1|drcA|drcA||1|||daptomycin_efflux_ABC_transporter_ATP-binding_protein_DrcA|AMR|peptide	44.5	220	222	255	9.97e-62	192
ShaoY_2019_ERR3405992_bin.9_k141_11446_31	SARG|gi|1001720867|ref|WP_061274204.1|	42.5	221	222	648	4.87e-52	176
ShaoY_2019_ERR3405992_bin.9_k141_11446_31	SARG|gi|1035706844|ref|WP_064548272.1|	42.5	221	222	648	6.77e-52	176
ShaoY_2019_ERR3405992_bin.9_k141_11446_31	SARG|gi|736472622|ref|WP_034494292.1|	42.1	221	222	648	1.81e-51	175
ShaoY_2019_ERR3405992_bin.9_k141_11446_31	SARG|gi|495736522|ref|WP_008461101.1|	42.1	221	222	648	2.52e-51	174
ShaoY_2019_ERR3405992_bin.9_k141_11446_31	SARG|gi|746253210|ref|WP_039301529.1|	42.1	221	222	648	2.52e-51	174
ShaoY_2019_ERR3405992_bin.9_k141_11446_31	SARG|gi|1035670474|ref|WP_064517458.1|	41.6	221	222	648	4.86e-51	174
ShaoY_2019_ERR3405992_bin.9_k141_11446_31	SARG|gi|1035717981|ref|WP_064557480.1|	41.6	221	222	648	4.86e-51	174
ShaoY_2019_ERR3405992_bin.9_k141_11446_31	SARG|gi|746243059|ref|WP_039291473.1|	42.1	221	222	648	6.74e-51	173
ShaoY_2019_ERR3405992_bin.9_k141_11446_31	SARG|gi|1033064422|ref|WP_064375412.1|	40.7	221	222	648	1.30e-50	172
ShaoY_2019_ERR3405992_bin.9_k141_16175_45	NCBI|WP_005480402.1|1|1|tet(35)|tet(35)|efflux|2|TETRACYCLINE|TETRACYCLINE|tetracycline_efflux_Na+/H+_antiporter_family_transporter_Tet(35)|AMR|tetracycline	38.6	526	526	533	1.38e-108	333
ShaoY_2019_ERR3405992_bin.9_k141_16175_45	SARG|AF353562.gene.p01	35.8	374	526	369	8.71e-65	214
ShaoY_2019_ERR3405992_bin.9_k141_16175_63	SARG|CAA37477	47.1	140	611	663	6.81e-29	120
ShaoY_2019_ERR3405992_bin.9_k141_16175_63	SARG|NP_348076	45.1	142	611	652	1.16e-27	117
ShaoY_2019_ERR3405992_bin.9_k141_16175_63	SARG|ZP_02952732	44.4	142	611	652	4.85e-27	115
ShaoY_2019_ERR3405992_bin.9_k141_16175_63	SARG|L20800.gene.p01	44.4	142	611	652	4.85e-27	115
ShaoY_2019_ERR3405992_bin.9_k141_16175_63	SARG|ZP_02632674	44.4	142	611	660	4.98e-27	115
ShaoY_2019_ERR3405992_bin.9_k141_16175_63	SARG|YP_002850805	43.0	142	611	652	6.46e-27	114
ShaoY_2019_ERR3405992_bin.9_k141_16175_63	SARG|ABN79417	41.5	142	611	639	4.48e-25	108
ShaoY_2019_ERR3405992_bin.9_k141_16175_63	megares|MEG_7169|Drugs|Tetracycline|Tetracycline_resistance_ribosomal_protection_proteins|TETO_1	41.5	142	611	629	7.68e-25	108
ShaoY_2019_ERR3405992_bin.9_k141_16175_63	megares|MEG_7170|Drugs|Tetracycline|Tetracycline_resistance_ribosomal_protection_proteins|TETO_1	41.5	142	611	629	7.68e-25	108
ShaoY_2019_ERR3405992_bin.9_k141_16175_63	megares|MEG_7173|Drugs|Tetracycline|Tetracycline_resistance_ribosomal_protection_proteins|TETO_1	41.5	142	611	629	7.68e-25	108
ShaoY_2019_ERR3405992_bin.9_k141_16175_100	NCBI|WP_000163435.1|1|1|mupA|mupA|insensitivity|2|mupirocin|mupirocin|mupirocin-resistant_isoleucine--tRNA_ligase_MupA|AMR|mupirocin	24.3	804	883	1024	9.17e-69	246
ShaoY_2019_ERR3405992_bin.9_k141_16175_100	megares|MEG_4089|Drugs|Mupirocin|Mupirocin-resistant_isoleucyl-tRNA_synthetase|MUPA_1	24.3	804	883	1024	9.17e-69	246
ShaoY_2019_ERR3405992_bin.9_k141_16175_100	megares|MEG_4090|Drugs|Mupirocin|Mupirocin-resistant_isoleucyl-tRNA_synthetase|MUPA_1	24.3	804	883	1024	1.69e-68	245
ShaoY_2019_ERR3405992_bin.9_k141_16175_100	SARG|gb|CAA53189|ARO:3000521|mupA	24.3	804	883	1024	1.69e-68	245
ShaoY_2019_ERR3405992_bin.9_k141_16175_105	SARG|gb|CAH14033.1|ARO:3004100|LpeB	25.1	835	1256	1014	2.70e-52	199
ShaoY_2019_ERR3405992_bin.9_k141_16175_105	CARD|gb|AAG07594.1|ARO:3000808|MexI	23.2	856	1256	1029	3.78e-44	173
ShaoY_2019_ERR3405992_bin.9_k141_16175_105	CARD|gb|ABS43151.1|ARO:3000784|cmeB	22.3	866	1256	1040	2.05e-40	161
ShaoY_2019_ERR3405992_bin.9_k141_16175_105	SARG|gi|654933144|ref|WP_028383500.1|	23.9	798	1256	1063	2.83e-40	161
ShaoY_2019_ERR3405992_bin.9_k141_16175_105	NCBI|WP_254563251.1|1|1|cmeB_RE|cmeB_RE|efflux|2|FLORFENICOL/quinolone|PHENICOL/quinolone|multidrug_efflux_RND_transporter_permease_subunit_CmeB,_ciprofloxacin_and_phenicol_resistance_type|AMR|multidrug	22.7	803	1256	1039	6.18e-40	160
ShaoY_2019_ERR3405992_bin.9_k141_16175_105	SARG|gi|780147796|ref|WP_045491627.1|	24.2	790	1256	1063	2.57e-39	158
ShaoY_2019_ERR3405992_bin.9_k141_16175_105	SARG|YP_607927	23.4	803	1256	1059	7.66e-39	156
ShaoY_2019_ERR3405992_bin.9_k141_16175_105	SARG|CAY49157	23.5	792	1256	1059	7.66e-39	156
ShaoY_2019_ERR3405992_bin.9_k141_16175_105	SARG|gi|803453816|ref|WP_046068030.1|	24.0	792	1256	1059	1.01e-38	156
ShaoY_2019_ERR3405992_bin.9_k141_16175_105	SARG|gi|740796309|ref|WP_038581593.1|	23.2	818	1256	1048	1.30e-38	155
ShaoY_2019_ERR3405992_bin.9_k141_16175_136	SARG|YP_001373621	29.2	216	362	318	1.59e-19	87.0
ShaoY_2019_ERR3405992_bin.9_k141_16175_136	SARG|gi|542061059|gb|ERI11611.1|	29.2	192	362	316	2.12e-19	86.7
ShaoY_2019_ERR3405992_bin.9_k141_16175_136	NCBI|QHA94808.1|1|1|narA|narA||1|MADURAMICIN/NARASIN/SALINOMYCIN|IONOPHORE|ionophore_ABC_transporter_ATP-binding_subunit_NarA|AMR|ionophore	30.1	219	362	293	1.04e-16	78.6
ShaoY_2019_ERR3405992_bin.9_k141_16175_136	SARG|gb|AAK76137.1|ARO:3000024|patA	27.6	199	362	564	3.06e-13	69.7
ShaoY_2019_ERR3405992_bin.9_k141_16175_136	SARG|gi|446048013|ref|WP_000125868.1|	25.1	199	362	648	7.88e-13	68.6
ShaoY_2019_ERR3405992_bin.9_k141_16175_136	SARG|gb|SOX29786.1|ARO:3004730|tva(A)	27.7	213	362	505	1.19e-12	67.8
ShaoY_2019_ERR3405992_bin.9_k141_16175_136	NCBI|WP_014936356.1|1|1|tva(B)|tva(B)|target_protection|2|TIAMULIN|PLEUROMUTILIN|ABC-F_type_ribosomal_protection_protein_Tva(B)|AMR|pleuromutilin	28.0	200	362	504	3.76e-12	66.2
ShaoY_2019_ERR3405992_bin.9_k141_16175_136	NCBI|AKC61310.1|1|1|cplR|cplR|target_protection|1|CLINDAMYCIN/LINCOMYCIN/RETAPAMULIN/VIRGINIAMYCIN|LINCOSAMIDE/PLEUROMUTILIN/STREPTOGRAMIN|ABC-F_type_ribosomal_protection_protein_CplR|AMR|multidrug	29.3	191	362	552	2.99e-11	63.5
ShaoY_2019_ERR3405992_bin.9_k141_16175_136	SARG|gb|AYV52072.1|ARO:3002882|lmrD	23.1	208	362	664	4.16e-09	57.0
ShaoY_2019_ERR3405992_bin.9_k141_16175_136	SARG|U82085.gene.p01	26.1	199	362	552	6.50e-08	53.1
ShaoY_2019_ERR3405992_bin.9_k141_16175_152	SARG|gb|AAC75314.1|ARO:3003578|pmrF	30.1	329	325	322	2.73e-38	137
ShaoY_2019_ERR3405992_bin.9_k141_16175_153	SARG|CAB61225	25.8	124	195	161	1.82e-06	45.1
ShaoY_2019_ERR3405992_bin.9_k141_16175_188	megares|MEG_4308|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	38.5	563	658	655	1.30e-118	367
ShaoY_2019_ERR3405992_bin.9_k141_16175_188	megares|MEG_4318|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	38.5	558	658	655	1.83e-118	367
ShaoY_2019_ERR3405992_bin.9_k141_16175_188	megares|MEG_4316|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	38.5	558	658	655	2.57e-118	366
ShaoY_2019_ERR3405992_bin.9_k141_16175_188	megares|MEG_4307|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	38.4	563	658	655	1.99e-117	364
ShaoY_2019_ERR3405992_bin.9_k141_16175_188	megares|MEG_4313|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	38.4	558	658	655	2.81e-117	363
ShaoY_2019_ERR3405992_bin.9_k141_16175_188	megares|MEG_4309|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	38.4	558	658	655	2.81e-117	363
ShaoY_2019_ERR3405992_bin.9_k141_16175_188	megares|MEG_4312|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	38.4	558	658	655	2.81e-117	363
ShaoY_2019_ERR3405992_bin.9_k141_16175_188	megares|MEG_4306|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	38.6	559	658	655	2.81e-117	363
ShaoY_2019_ERR3405992_bin.9_k141_16175_188	megares|MEG_4311|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	38.4	558	658	655	2.81e-117	363
ShaoY_2019_ERR3405992_bin.9_k141_16175_188	megares|MEG_4315|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	38.4	558	658	655	2.81e-117	363
ShaoY_2019_ERR3405992_bin.9_k141_17051_19	NCBI|WP_063856408.1|1|1|tet(Q)|tet(Q)|target_protection|2|TETRACYCLINE|TETRACYCLINE|tetracycline_resistance_ribosomal_protection_protein_Tet(Q)|AMR|tetracycline	25.9	459	531	654	1.09e-33	134
ShaoY_2019_ERR3405992_bin.9_k141_17051_19	megares|MEG_7182|Drugs|Tetracycline|Tetracycline_resistance_ribosomal_protection_proteins|TETQ_1	25.9	459	531	670	1.17e-33	134
ShaoY_2019_ERR3405992_bin.9_k141_17051_19	SARG|AAB51122	25.9	459	531	670	1.17e-33	134
ShaoY_2019_ERR3405992_bin.9_k141_17051_19	SARG|Q08425	25.9	459	531	641	1.85e-33	133
ShaoY_2019_ERR3405992_bin.9_k141_17051_19	megares|MEG_7181|Drugs|Tetracycline|Tetracycline_resistance_ribosomal_protection_proteins|TETQ_1	25.9	459	531	657	2.00e-33	133
ShaoY_2019_ERR3405992_bin.9_k141_17051_19	SARG|Z21523.gene.p01	25.9	459	531	657	2.00e-33	133
ShaoY_2019_ERR3405992_bin.9_k141_17051_19	NCBI|WP_063856409.1|1|1|tet(Q)|tet(Q)|target_protection|2|TETRACYCLINE|TETRACYCLINE|tetracycline_resistance_ribosomal_protection_protein_Tet(Q)|AMR|tetracycline	25.6	464	531	641	2.01e-32	130
ShaoY_2019_ERR3405992_bin.9_k141_17051_19	SARG|AAZ79478	25.6	464	531	657	2.16e-32	130
ShaoY_2019_ERR3405992_bin.9_k141_17051_19	SARG|Q52360	25.9	452	531	641	2.16e-31	127
ShaoY_2019_ERR3405992_bin.9_k141_17051_19	SARG|P70882	25.9	452	531	641	2.16e-31	127
ShaoY_2019_ERR3405992_bin.9_k141_17455_11	SARG|gb|ABA71733.1|ARO:3002972|vanTG	36.3	372	377	712	2.96e-67	224
ShaoY_2019_ERR3405992_bin.9_k141_17455_11	NCBI|WP_063856752.1|1|1|vanT-G|vanT-G|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|membrane-bound_serine_racemase_VanT-G|AMR|glycopeptide	34.9	372	377	711	1.51e-57	198
ShaoY_2019_ERR3405992_bin.9_k141_17455_11	NCBI|CZR78671.1|1|1|vanT-Cd|vanT-Cd|re-structuring_of_the_cell_wall|1|VANCOMYCIN|GLYCOPEPTIDE|membrane-bound_serine_racemase_VanT-Cd|AMR|glycopeptide	31.8	371	377	712	3.28e-51	181
ShaoY_2019_ERR3405992_bin.9_k141_17455_11	SARG|gb|ABX54690.1|ARO:3002974|vanTrL	31.2	372	377	366	1.98e-50	172
ShaoY_2019_ERR3405992_bin.9_k141_17455_22	SARG|ZP_02632674	26.2	679	697	660	2.67e-58	207
ShaoY_2019_ERR3405992_bin.9_k141_17455_22	SARG|YP_002850805	26.6	673	697	652	3.23e-58	207
ShaoY_2019_ERR3405992_bin.9_k141_17455_22	SARG|ZP_02952732	26.3	673	697	652	6.10e-58	206
ShaoY_2019_ERR3405992_bin.9_k141_17455_22	SARG|L20800.gene.p01	26.3	673	697	652	6.10e-58	206
ShaoY_2019_ERR3405992_bin.9_k141_17455_22	SARG|NP_348076	25.8	683	697	652	1.46e-56	202
ShaoY_2019_ERR3405992_bin.9_k141_17455_22	SARG|AAV80410	24.8	666	697	651	5.74e-51	187
ShaoY_2019_ERR3405992_bin.9_k141_17455_22	SARG|L42544.gene.p01	24.8	666	697	651	1.46e-50	186
ShaoY_2019_ERR3405992_bin.9_k141_17455_22	SARG|AJ514254.gene.p01	23.1	662	697	640	5.41e-45	169
ShaoY_2019_ERR3405992_bin.9_k141_17455_22	NCBI|WP_050824634.1|1|1|tet(O)|tet(O)|target_protection|2|TETRACYCLINE|TETRACYCLINE|tetracycline_resistance_ribosomal_protection_protein_Tet(O)|AMR|tetracycline	23.6	678	697	639	4.27e-42	161
ShaoY_2019_ERR3405992_bin.9_k141_17455_22	SARG|gi|544707441|ref|WP_021137831.1|	23.1	672	697	639	5.77e-42	160
ShaoY_2019_ERR3405992_bin.9_k141_17455_35	megares|MEG_1992|Drugs|beta-lactam|Class_C_betalactamases|CMY_1	34.7	124	302	291	3.66e-11	61.6
ShaoY_2019_ERR3405992_bin.9_k141_17455_37	NCBI|WP_000163435.1|1|1|mupA|mupA|insensitivity|2|mupirocin|mupirocin|mupirocin-resistant_isoleucine--tRNA_ligase_MupA|AMR|mupirocin	22.8	724	805	1024	6.46e-18	87.8
ShaoY_2019_ERR3405992_bin.9_k141_17455_37	megares|MEG_4089|Drugs|Mupirocin|Mupirocin-resistant_isoleucyl-tRNA_synthetase|MUPA_1	22.8	724	805	1024	6.46e-18	87.8
ShaoY_2019_ERR3405992_bin.9_k141_17455_37	megares|MEG_4090|Drugs|Mupirocin|Mupirocin-resistant_isoleucyl-tRNA_synthetase|MUPA_1	22.8	724	805	1024	6.46e-18	87.8
ShaoY_2019_ERR3405992_bin.9_k141_17455_37	SARG|gb|CAA53189|ARO:3000521|mupA	22.8	724	805	1024	6.46e-18	87.8
ShaoY_2019_ERR3405992_bin.9_k141_17455_41	SARG|gi|740856590|ref|WP_038641842.1|	40.6	244	262	648	5.44e-43	153
ShaoY_2019_ERR3405992_bin.9_k141_17455_41	SARG|gi|754951242|ref|WP_042307417.1|	40.6	244	262	648	7.51e-43	153
ShaoY_2019_ERR3405992_bin.9_k141_17455_41	SARG|gi|493734654|ref|WP_006683876.1|	40.6	244	262	648	7.51e-43	153
ShaoY_2019_ERR3405992_bin.9_k141_17455_41	SARG|gi|507086196|ref|WP_016156937.1|	40.2	244	262	648	3.74e-42	151
ShaoY_2019_ERR3405992_bin.9_k141_17455_41	SARG|gi|922960663|ref|WP_053388845.1|	40.2	244	262	648	5.15e-42	150
ShaoY_2019_ERR3405992_bin.9_k141_17455_41	SARG|gi|757799695|ref|WP_043016897.1|	40.2	244	262	648	7.09e-42	150
ShaoY_2019_ERR3405992_bin.9_k141_17455_41	SARG|gi|1045891604|ref|WP_065554100.1|	40.2	244	262	648	7.09e-42	150
ShaoY_2019_ERR3405992_bin.9_k141_17455_41	SARG|gi|507082903|ref|WP_016153652.1|	40.2	244	262	648	7.09e-42	150
ShaoY_2019_ERR3405992_bin.9_k141_17455_41	SARG|gi|835233765|ref|WP_047410073.1|	40.2	244	262	648	9.77e-42	150
ShaoY_2019_ERR3405992_bin.9_k141_17455_41	SARG|gi|992380339|ref|WP_061067665.1|	39.4	254	262	648	1.85e-41	149
ShaoY_2019_ERR3405992_bin.9_k141_17455_51	SARG|gb|AAG05187.1|ARO:3005067|ParS	29.6	240	386	428	1.33e-25	106
ShaoY_2019_ERR3405992_bin.9_k141_17455_51	NCBI|WP_063856732.1|1|1|vanS-G|vanS-G|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_histidine_kinase_VanS-G|AMR|glycopeptide	30.3	201	386	367	1.20e-22	97.1
ShaoY_2019_ERR3405992_bin.9_k141_17455_51	NCBI|WP_021418927.1|1|1|vanS-G|vanS-G|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_histidine_kinase_VanS-G|AMR|glycopeptide	30.3	201	386	368	1.21e-22	97.1
ShaoY_2019_ERR3405992_bin.9_k141_17455_51	CARD|gb|ADM92606.1|ARO:3000549|adeS	30.6	229	386	361	1.79e-19	87.8
ShaoY_2019_ERR3405992_bin.9_k141_17455_51	NCBI|WP_063856734.1|1|1|vanS-E|vanS-E|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_histidine_kinase_VanS-E|AMR|glycopeptide	27.5	200	386	357	1.19e-17	82.4
ShaoY_2019_ERR3405992_bin.9_k141_17455_51	megares|MEG_7511|Drugs|Glycopeptide|VanE-type_regulator|VANSE_1	27.5	200	386	357	1.19e-17	82.4
ShaoY_2019_ERR3405992_bin.9_k141_17455_51	NCBI|AXB64455.1|1|1|vanS-Cd|vanS-Cd|re-structuring_of_the_cell_wall|1|VANCOMYCIN|GLYCOPEPTIDE|VanG-Cd-type_glycopeptide_resistance_histidine_kinase_VanS|AMR|glycopeptide	26.9	201	386	380	1.43e-17	82.4
ShaoY_2019_ERR3405992_bin.9_k141_17455_51	megares|MEG_7498|Drugs|Glycopeptide|VanC-type_regulator|VANSC_1	26.9	201	386	380	1.43e-17	82.4
ShaoY_2019_ERR3405992_bin.9_k141_17455_51	NCBI|WP_222891058.1|1|1|vanS-P|vanS-P|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_histidine_kinase_VanS-P|AMR|glycopeptide	26.7	202	386	359	2.99e-17	81.3
ShaoY_2019_ERR3405992_bin.9_k141_17455_51	megares|MEG_7514|Drugs|Glycopeptide|VanL-type_regulator|VANSL_1	28.2	255	386	364	8.26e-16	77.0
ShaoY_2019_ERR3405992_bin.9_k141_17455_52	NCBI|WP_011029105.1|1|1|vanR-Sc|vanR-Sc|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-Sc|AMR|glycopeptide	38.0	221	227	231	1.50e-42	142
ShaoY_2019_ERR3405992_bin.9_k141_17455_52	NCBI|WP_063856729.1|1|1|vanR-O|vanR-O|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-O|AMR|glycopeptide	36.3	226	227	233	8.89e-42	140
ShaoY_2019_ERR3405992_bin.9_k141_17455_52	CARD|gb|ATC67679.1|ARO:3000838|arlR	36.6	224	227	219	1.67e-38	132
ShaoY_2019_ERR3405992_bin.9_k141_17455_52	NCBI|WP_063856723.1|1|1|vanR-B|vanR-B|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-B|AMR|glycopeptide	35.4	223	227	219	1.32e-37	129
ShaoY_2019_ERR3405992_bin.9_k141_17455_52	NCBI|WP_063856719.1|1|1|vanR-B|vanR-B|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-B|AMR|glycopeptide	34.7	225	227	220	3.79e-37	128
ShaoY_2019_ERR3405992_bin.9_k141_17455_52	NCBI|WP_002317273.1|1|1|vanR-B|vanR-B|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-B|AMR|glycopeptide	35.0	223	227	219	5.21e-37	128
ShaoY_2019_ERR3405992_bin.9_k141_17455_52	NCBI|WP_032489743.1|1|1|vanR-B|vanR-B|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-B|AMR|glycopeptide	34.7	225	227	220	5.34e-37	128
ShaoY_2019_ERR3405992_bin.9_k141_17455_52	SARG|ZP_02848503	35.3	224	227	221	3.05e-36	126
ShaoY_2019_ERR3405992_bin.9_k141_17455_52	NCBI|WP_002368697.1|1|1|vanR-B|vanR-B|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-B|AMR|glycopeptide	34.4	224	227	220	4.19e-36	125
ShaoY_2019_ERR3405992_bin.9_k141_17455_52	CARD|gb|SIP52035.1|ARO:3004054|Paer_CpxR	33.5	218	227	225	1.34e-35	124
ShaoY_2019_ERR3405992_bin.9_k141_17455_65	NCBI|WP_063856748.1|1|1|vanS-M|vanS-M|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_histidine_kinase_VanS-M|AMR|glycopeptide	25.5	274	477	370	1.08e-25	107
ShaoY_2019_ERR3405992_bin.9_k141_17455_65	CARD|gb|ABD30512.1|ARO:3000839|arlS	30.2	301	477	451	1.21e-24	105
ShaoY_2019_ERR3405992_bin.9_k141_17455_65	NCBI|WP_006285582.1|1|1|vanS-F|vanS-F|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_histidine_kinase_VanS-F|AMR|glycopeptide	25.1	275	477	365	2.50e-23	100
ShaoY_2019_ERR3405992_bin.9_k141_17455_65	NCBI|WP_021418927.1|1|1|vanS-G|vanS-G|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_histidine_kinase_VanS-G|AMR|glycopeptide	28.7	247	477	368	6.52e-20	90.1
ShaoY_2019_ERR3405992_bin.9_k141_17455_65	megares|MEG_7507|Drugs|Glycopeptide|VanD-type_regulator|VANSD_1	29.0	252	477	381	7.40e-20	90.1
ShaoY_2019_ERR3405992_bin.9_k141_17455_65	NCBI|WP_063856738.1|1|1|vanS-D|vanS-D|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_histidine_kinase_VanS-D|AMR|glycopeptide	29.0	252	477	381	7.40e-20	90.1
ShaoY_2019_ERR3405992_bin.9_k141_17455_65	NCBI|WP_063856732.1|1|1|vanS-G|vanS-G|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_histidine_kinase_VanS-G|AMR|glycopeptide	28.7	244	477	367	1.17e-19	89.4
ShaoY_2019_ERR3405992_bin.9_k141_17455_65	NCBI|WP_063856744.1|1|1|vanS-D|vanS-D|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_histidine_kinase_VanS-D|AMR|glycopeptide	28.0	250	477	381	3.26e-19	88.2
ShaoY_2019_ERR3405992_bin.9_k141_17455_65	megares|MEG_7504|Drugs|Glycopeptide|VanD-type_regulator|VANSD_1	28.0	250	477	381	3.26e-19	88.2
ShaoY_2019_ERR3405992_bin.9_k141_17455_65	NCBI|WP_023042297.1|1|1|vanS-D|vanS-D|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_histidine_kinase_VanS-D|AMR|glycopeptide	28.0	254	477	381	4.38e-19	87.8
ShaoY_2019_ERR3405992_bin.9_k141_17455_66	CARD|gb|ATC67679.1|ARO:3000838|arlR	40.6	217	221	219	2.45e-48	157
ShaoY_2019_ERR3405992_bin.9_k141_17455_66	NCBI|WP_063856718.1|1|1|vanR-E|vanR-E|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-E|AMR|glycopeptide	39.0	228	221	229	7.37e-47	153
ShaoY_2019_ERR3405992_bin.9_k141_17455_66	NCBI|WP_032489743.1|1|1|vanR-B|vanR-B|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-B|AMR|glycopeptide	38.8	214	221	220	4.55e-46	151
ShaoY_2019_ERR3405992_bin.9_k141_17455_66	NCBI|WP_002317273.1|1|1|vanR-B|vanR-B|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-B|AMR|glycopeptide	38.8	214	221	219	8.83e-46	150
ShaoY_2019_ERR3405992_bin.9_k141_17455_66	NCBI|WP_063856719.1|1|1|vanR-B|vanR-B|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-B|AMR|glycopeptide	38.8	214	221	220	9.09e-46	150
ShaoY_2019_ERR3405992_bin.9_k141_17455_66	NCBI|WP_063856723.1|1|1|vanR-B|vanR-B|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-B|AMR|glycopeptide	38.3	214	221	219	7.04e-45	148
ShaoY_2019_ERR3405992_bin.9_k141_17455_66	NCBI|WP_063856728.1|1|1|vanR-N|vanR-N|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-N|AMR|glycopeptide	37.1	229	221	230	1.35e-44	147
ShaoY_2019_ERR3405992_bin.9_k141_17455_66	NCBI|WP_063856726.1|1|1|vanR-M|vanR-M|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-M|AMR|glycopeptide	38.4	224	221	232	8.05e-44	145
ShaoY_2019_ERR3405992_bin.9_k141_17455_66	NCBI|WP_006285581.1|1|1|vanR-F|vanR-F|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-F|AMR|glycopeptide	37.5	224	221	231	4.40e-43	144
ShaoY_2019_ERR3405992_bin.9_k141_17455_66	NCBI|WP_002368697.1|1|1|vanR-B|vanR-B|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-B|AMR|glycopeptide	37.4	214	221	220	6.47e-43	143
ShaoY_2019_ERR3405992_bin.9_k141_17525_19	SARG|gi|488374619|ref|WP_002444004.1|	23.3	412	454	452	1.33e-30	122
ShaoY_2019_ERR3405992_bin.9_k141_17525_25	SARG|gb|WP_104671188.1|ARO:3003948|efrA	42.3	525	752	575	8.66e-131	399
ShaoY_2019_ERR3405992_bin.9_k141_17525_25	SARG|gb|AAK76137.1|ARO:3000024|patA	37.1	517	752	564	8.76e-107	336
ShaoY_2019_ERR3405992_bin.9_k141_17525_25	SARG|gi|558888514|ref|WP_023543283.1|	32.0	497	752	615	2.37e-66	230
ShaoY_2019_ERR3405992_bin.9_k141_17525_25	SARG|AF170880.4.gene1.p01	32.0	497	752	615	3.28e-66	229
ShaoY_2019_ERR3405992_bin.9_k141_17525_25	SARG|gi|695842130|ref|WP_032755430.1|	31.9	486	752	603	1.25e-64	225
ShaoY_2019_ERR3405992_bin.9_k141_17525_25	SARG|gi|505420018|ref|WP_015607120.1|	31.9	486	752	603	1.25e-64	225
ShaoY_2019_ERR3405992_bin.9_k141_17525_25	SARG|gi|662129758|ref|WP_030081404.1|	31.6	484	752	605	1.30e-64	225
ShaoY_2019_ERR3405992_bin.9_k141_17525_25	SARG|gi|664085850|ref|WP_030624018.1|	31.6	484	752	605	1.79e-64	224
ShaoY_2019_ERR3405992_bin.9_k141_17525_25	SARG|gi|930482089|ref|WP_054228897.1|	30.5	547	752	599	4.18e-64	223
ShaoY_2019_ERR3405992_bin.9_k141_17525_25	SARG|gi|517347347|ref|WP_018522839.1|	30.0	504	752	601	4.35e-64	223
ShaoY_2019_ERR3405992_bin.9_k141_17525_26	SARG|gb|CDO61516.1|ARO:3003949|efrB	54.3	326	618	362	5.50e-116	349
ShaoY_2019_ERR3405992_bin.9_k141_17525_26	SARG|gb|AAK76136.1|ARO:3000025|patB	36.7	581	618	588	7.57e-114	351
ShaoY_2019_ERR3405992_bin.9_k141_17525_26	SARG|gb|AYV52072.1|ARO:3002882|lmrD	37.9	515	618	664	2.30e-104	329
ShaoY_2019_ERR3405992_bin.9_k141_17525_26	SARG|gi|748767925|ref|WP_040019608.1|	38.3	517	618	623	3.47e-87	283
ShaoY_2019_ERR3405992_bin.9_k141_17525_26	SARG|gi|928900436|ref|WP_053931243.1|	33.3	586	618	600	1.07e-86	281
ShaoY_2019_ERR3405992_bin.9_k141_17525_26	SARG|gi|702897513|ref|WP_033300957.1|	38.0	510	618	601	1.10e-86	281
ShaoY_2019_ERR3405992_bin.9_k141_17525_26	SARG|gi|664579989|ref|WP_031094015.1|	33.3	586	618	601	1.10e-86	281
ShaoY_2019_ERR3405992_bin.9_k141_17525_26	SARG|gi|944009777|ref|WP_055601444.1|	33.0	584	618	628	8.04e-86	279
ShaoY_2019_ERR3405992_bin.9_k141_17525_26	SARG|gi|817122037|ref|WP_046494699.1|	37.2	516	618	613	1.10e-85	278
ShaoY_2019_ERR3405992_bin.9_k141_17525_26	SARG|gi|1033217078|gb|OAR27197.1|	32.9	587	618	601	2.26e-85	277
ShaoY_2019_ERR3405992_bin.9_k141_17525_32	SARG|gb|ADZ12699.1|ARO:3005091|RanA	31.0	248	358	258	1.24e-30	116
ShaoY_2019_ERR3405992_bin.9_k141_17525_32	SARG|gi|507050365|ref|WP_016121371.1|	24.9	289	358	309	9.75e-23	95.9
ShaoY_2019_ERR3405992_bin.9_k141_17525_32	SARG|gi|895865878|ref|WP_048974758.1|	31.8	220	358	646	1.24e-22	98.2
ShaoY_2019_ERR3405992_bin.9_k141_17525_32	SARG|gb|AYV52072.1|ARO:3002882|lmrD	29.0	214	358	664	4.01e-17	81.6
ShaoY_2019_ERR3405992_bin.9_k141_17525_32	SARG|gb|CDO61516.1|ARO:3003949|efrB	29.8	205	358	362	8.57e-16	76.6
ShaoY_2019_ERR3405992_bin.9_k141_17525_32	SARG|gb|AAK76136.1|ARO:3000025|patB	26.5	211	358	588	4.00e-14	72.4
ShaoY_2019_ERR3405992_bin.9_k141_17525_32	NCBI|WP_289811733.1|1|1|tetB(60)|tetB(60)||2|TETRACYCLINE|TETRACYCLINE|tetracycline_efflux_ABC_transporter_Tet(60)_subunit_B|AMR|tetracycline	27.6	232	358	579	5.29e-14	72.0
ShaoY_2019_ERR3405992_bin.9_k141_17525_32	megares|MEG_4311|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	27.3	216	358	655	5.69e-14	72.0
ShaoY_2019_ERR3405992_bin.9_k141_17525_32	megares|MEG_4305|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	27.3	216	358	655	5.69e-14	72.0
ShaoY_2019_ERR3405992_bin.9_k141_17525_32	megares|MEG_4316|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	27.3	216	358	655	1.35e-13	70.9
ShaoY_2019_ERR3405992_bin.9_k141_17525_36	NCBI|WP_002389535.1|1|1|bcrA_Lm|bcrA_Lm||2|peptide|peptide|peptide_resistance_ABC_transporter_ATP-binding_subunit_BcrA|AMR|peptide	26.8	231	303	307	3.29e-17	79.3
ShaoY_2019_ERR3405992_bin.9_k141_17653_41	NCBI|WP_006285581.1|1|1|vanR-F|vanR-F|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-F|AMR|glycopeptide	44.3	230	227	231	9.71e-58	181
ShaoY_2019_ERR3405992_bin.9_k141_17653_41	NCBI|WP_063856726.1|1|1|vanR-M|vanR-M|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-M|AMR|glycopeptide	43.1	232	227	232	2.28e-56	178
ShaoY_2019_ERR3405992_bin.9_k141_17653_41	NCBI|WP_032489743.1|1|1|vanR-B|vanR-B|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-B|AMR|glycopeptide	42.5	221	227	220	5.13e-55	174
ShaoY_2019_ERR3405992_bin.9_k141_17653_41	NCBI|WP_002317273.1|1|1|vanR-B|vanR-B|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-B|AMR|glycopeptide	42.5	221	227	219	7.04e-55	174
ShaoY_2019_ERR3405992_bin.9_k141_17653_41	NCBI|WP_063856719.1|1|1|vanR-B|vanR-B|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-B|AMR|glycopeptide	42.5	221	227	220	7.26e-55	174
ShaoY_2019_ERR3405992_bin.9_k141_17653_41	NCBI|WP_063856723.1|1|1|vanR-B|vanR-B|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-B|AMR|glycopeptide	42.1	221	227	219	5.66e-54	171
ShaoY_2019_ERR3405992_bin.9_k141_17653_41	NCBI|WP_011461303.1|1|1|vanR-I|vanR-I|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-I|AMR|glycopeptide	39.5	228	227	232	3.34e-53	170
ShaoY_2019_ERR3405992_bin.9_k141_17653_41	megares|MEG_7482|Drugs|Glycopeptide|VanL-type_regulator|VANRI_1	39.5	228	227	232	3.34e-53	170
ShaoY_2019_ERR3405992_bin.9_k141_17653_41	NCBI|WP_002368697.1|1|1|vanR-B|vanR-B|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-B|AMR|glycopeptide	42.1	221	227	220	6.62e-53	169
ShaoY_2019_ERR3405992_bin.9_k141_17653_41	NCBI|WP_063856728.1|1|1|vanR-N|vanR-N|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-N|AMR|glycopeptide	38.4	229	227	230	3.57e-52	167
ShaoY_2019_ERR3405992_bin.9_k141_17653_42	NCBI|WP_002368696.1|1|1|vanS-B|vanS-B|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_histidine_kinase_VanS-B|AMR|glycopeptide	30.0	310	492	447	2.39e-34	133
ShaoY_2019_ERR3405992_bin.9_k141_17653_42	NCBI|WP_002382867.1|1|1|vanS-B|vanS-B|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_histidine_kinase_VanS-B|AMR|glycopeptide	29.5	312	492	447	6.13e-34	132
ShaoY_2019_ERR3405992_bin.9_k141_17653_42	NCBI|WP_012579101.1|1|1|vanS-B|vanS-B|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_histidine_kinase_VanS-B|AMR|glycopeptide	29.5	312	492	447	6.13e-34	132
ShaoY_2019_ERR3405992_bin.9_k141_17653_42	NCBI|WP_063856739.1|1|1|vanS-B|vanS-B|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_histidine_kinase_VanS-B|AMR|glycopeptide	29.5	312	492	447	6.13e-34	132
ShaoY_2019_ERR3405992_bin.9_k141_17653_42	NCBI|WP_063856751.1|1|1|vanS-B|vanS-B|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_histidine_kinase_VanS-B|AMR|glycopeptide	28.5	312	492	454	7.33e-32	126
ShaoY_2019_ERR3405992_bin.9_k141_17653_42	NCBI|WP_063856734.1|1|1|vanS-E|vanS-E|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_histidine_kinase_VanS-E|AMR|glycopeptide	28.9	211	492	357	3.17e-21	94.0
ShaoY_2019_ERR3405992_bin.9_k141_17653_42	megares|MEG_7511|Drugs|Glycopeptide|VanE-type_regulator|VANSE_1	28.9	211	492	357	3.17e-21	94.0
ShaoY_2019_ERR3405992_bin.9_k141_17653_42	NCBI|WP_222891058.1|1|1|vanS-P|vanS-P|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_histidine_kinase_VanS-P|AMR|glycopeptide	25.6	234	492	359	2.86e-19	88.2
ShaoY_2019_ERR3405992_bin.9_k141_17653_42	megares|MEG_7486|Drugs|Glycopeptide|VanA-type_regulator|VANSA_1	26.6	282	492	382	3.58e-19	88.2
ShaoY_2019_ERR3405992_bin.9_k141_17653_42	NCBI|WP_063856731.1|1|1|vanS-A|vanS-A|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_histidine_kinase_VanS-A|AMR|glycopeptide	26.6	282	492	382	3.58e-19	88.2
ShaoY_2019_ERR3405992_bin.9_k141_17653_47	megares|MEG_4309|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	28.9	519	547	655	2.97e-69	234
ShaoY_2019_ERR3405992_bin.9_k141_17653_47	megares|MEG_4304|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	28.7	519	547	655	4.14e-69	233
ShaoY_2019_ERR3405992_bin.9_k141_17653_47	SARG|gb|AKA86814|ARO:3003746|optrA	28.7	519	547	655	4.14e-69	233
ShaoY_2019_ERR3405992_bin.9_k141_17653_47	megares|MEG_4306|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	28.9	519	547	655	8.01e-69	233
ShaoY_2019_ERR3405992_bin.9_k141_17653_47	megares|MEG_4313|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	28.7	519	547	655	1.11e-68	232
ShaoY_2019_ERR3405992_bin.9_k141_17653_47	megares|MEG_4307|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	28.7	519	547	655	1.11e-68	232
ShaoY_2019_ERR3405992_bin.9_k141_17653_47	megares|MEG_4322|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	28.7	519	547	655	1.11e-68	232
ShaoY_2019_ERR3405992_bin.9_k141_17653_47	megares|MEG_4312|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	28.7	519	547	655	1.11e-68	232
ShaoY_2019_ERR3405992_bin.9_k141_17653_47	megares|MEG_4315|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	28.7	519	547	655	1.11e-68	232
ShaoY_2019_ERR3405992_bin.9_k141_17653_47	megares|MEG_4318|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	28.7	519	547	655	2.16e-68	231
ShaoY_2019_ERR3405992_bin.9_k141_17653_65	NCBI|XSG12260.1|1|1|drcA|drcA||1|||daptomycin_efflux_ABC_transporter_ATP-binding_protein_DrcA|AMR|peptide	38.5	221	247	255	1.22e-43	147
ShaoY_2019_ERR3405992_bin.9_k141_17653_65	SARG|gi|974588181|ref|WP_059178476.1|	39.1	220	247	646	3.35e-43	153
ShaoY_2019_ERR3405992_bin.9_k141_17653_65	SARG|YP_001176128	39.1	220	247	646	3.35e-43	153
ShaoY_2019_ERR3405992_bin.9_k141_17653_65	SARG|gi|757782629|ref|WP_043001213.1|	40.0	220	247	648	4.69e-43	153
ShaoY_2019_ERR3405992_bin.9_k141_17653_65	SARG|gi|992390012|ref|WP_061077002.1|	40.0	220	247	648	4.69e-43	153
ShaoY_2019_ERR3405992_bin.9_k141_17653_65	SARG|gi|763407609|ref|WP_044264203.1|	40.0	220	247	648	4.69e-43	153
ShaoY_2019_ERR3405992_bin.9_k141_17653_65	SARG|gi|754927849|ref|WP_042284850.1|	40.0	220	247	648	6.48e-43	152
ShaoY_2019_ERR3405992_bin.9_k141_17653_65	SARG|gi|817104523|ref|WP_046477871.1|	40.0	220	247	648	8.93e-43	152
ShaoY_2019_ERR3405992_bin.9_k141_17653_65	SARG|gi|764278838|ref|WP_044327089.1|	40.0	220	247	648	8.93e-43	152
ShaoY_2019_ERR3405992_bin.9_k141_17653_65	SARG|gi|968563772|ref|WP_058587854.1|	39.5	220	247	648	1.23e-42	152
ShaoY_2019_ERR3405992_bin.9_k141_17653_92	CARD|gb|ALH22601.1|ARO:3000620|adeL	27.4	288	297	337	6.90e-13	67.0
ShaoY_2019_ERR3405992_bin.9_k141_18606_4	megares|MEG_5396|Drugs|Aminocoumarins|Aminocoumarin-resistant_DNA_topoisomerases|PARY_1	44.9	683	646	703	3.59e-176	516
ShaoY_2019_ERR3405992_bin.9_k141_18606_18	CARD|gb|BAB36671.1|ARO:3000832|evgA	32.2	208	215	204	3.16e-31	112
ShaoY_2019_ERR3405992_bin.9_k141_18606_18	megares|MEG_4078|Drugs|Multi-drug_resistance|Multi-drug_RND_efflux_regulator|MTRAD_1	30.1	113	215	228	1.04e-09	55.5
ShaoY_2019_ERR3405992_bin.9_k141_18606_18	CARD|gb|AAG06465.1|ARO:3005063|cprR	29.5	112	215	223	1.20e-08	52.4
ShaoY_2019_ERR3405992_bin.9_k141_18606_18	CARD|gb|ATC67679.1|ARO:3000838|arlR	26.1	115	215	219	7.39e-08	50.1
ShaoY_2019_ERR3405992_bin.9_k141_18606_18	NCBI|WP_006285581.1|1|1|vanR-F|vanR-F|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-F|AMR|glycopeptide	30.9	110	215	231	3.73e-07	48.1
ShaoY_2019_ERR3405992_bin.9_k141_20244_68	SARG|ZP_04081918	36.1	313	315	306	1.20e-50	169
ShaoY_2019_ERR3405992_bin.9_k141_20244_68	SARG|YP_001373621	34.5	313	315	318	6.98e-49	164
ShaoY_2019_ERR3405992_bin.9_k141_20244_68	SARG|P42332	34.5	313	315	306	2.82e-48	162
ShaoY_2019_ERR3405992_bin.9_k141_20244_68	megares|MEG_1213|Drugs|Bacitracin|Bacitracin_ABC_transporter|BCRA_1	34.5	313	315	306	2.82e-48	162
ShaoY_2019_ERR3405992_bin.9_k141_20244_68	SARG|gi|510143239|gb|AGN36970.1|	34.5	313	315	313	3.38e-48	162
ShaoY_2019_ERR3405992_bin.9_k141_20244_68	SARG|ABB80128	34.5	313	315	306	3.97e-48	162
ShaoY_2019_ERR3405992_bin.9_k141_20244_68	SARG|gi|500194536|ref|WP_011867743.1|	35.5	313	315	306	3.97e-48	162
ShaoY_2019_ERR3405992_bin.9_k141_20244_68	SARG|gi|447195835|ref|WP_001273091.1|	35.5	313	315	306	3.97e-48	162
ShaoY_2019_ERR3405992_bin.9_k141_20244_68	SARG|gi|447195836|ref|WP_001273092.1|	35.1	313	315	306	1.10e-47	161
ShaoY_2019_ERR3405992_bin.9_k141_20244_68	SARG|AAD21213	33.9	313	315	306	2.18e-47	160
ShaoY_2019_ERR3405992_bin.9_k141_20244_81	megares|MEG_5396|Drugs|Aminocoumarins|Aminocoumarin-resistant_DNA_topoisomerases|PARY_1	40.1	689	641	703	1.64e-142	430
ShaoY_2019_ERR3405992_bin.9_k141_20244_90	SARG|gb|APB03214.1|ARO:3003980|tetA(48)	30.4	230	302	343	5.54e-29	112
ShaoY_2019_ERR3405992_bin.9_k141_20244_90	NCBI|WP_002389535.1|1|1|bcrA_Lm|bcrA_Lm||2|peptide|peptide|peptide_resistance_ABC_transporter_ATP-binding_subunit_BcrA|AMR|peptide	31.8	239	302	307	1.10e-28	110
ShaoY_2019_ERR3405992_bin.9_k141_20244_90	SARG|YP_001373621	31.4	220	302	318	6.95e-28	108
ShaoY_2019_ERR3405992_bin.9_k141_20309_12	SARG|ZP_04679156	27.4	442	466	451	1.14e-37	142
ShaoY_2019_ERR3405992_bin.9_k141_20309_12	SARG|gb|CAE00499.1|ARO:3003835|cdeA	26.3	437	466	441	4.75e-30	120
ShaoY_2019_ERR3405992_bin.9_k141_20309_12	SARG|HE999704.1.gene3064.p01	30.0	210	466	241	3.21e-16	77.0
ShaoY_2019_ERR3405992_bin.9_k141_20309_12	SARG|gi|441475675|emb|CCQ25429.1|	31.5	168	466	211	5.89e-12	63.9
ShaoY_2019_ERR3405992_bin.9_k141_20309_45	SARG|L42544.gene.p01	31.6	668	931	651	2.32e-84	283
ShaoY_2019_ERR3405992_bin.9_k141_20309_45	SARG|AAV80410	31.3	668	931	651	6.02e-83	280
ShaoY_2019_ERR3405992_bin.9_k141_20309_45	SARG|YP_002850805	32.5	664	931	652	2.19e-81	275
ShaoY_2019_ERR3405992_bin.9_k141_20309_45	SARG|ZP_02952732	32.1	660	931	652	2.12e-80	273
ShaoY_2019_ERR3405992_bin.9_k141_20309_45	SARG|L20800.gene.p01	32.1	660	931	652	2.12e-80	273
ShaoY_2019_ERR3405992_bin.9_k141_20309_45	SARG|ZP_02632674	32.1	660	931	660	2.53e-80	273
ShaoY_2019_ERR3405992_bin.9_k141_20309_45	SARG|NP_348076	31.0	667	931	652	4.05e-80	272
ShaoY_2019_ERR3405992_bin.9_k141_20309_45	NCBI|WP_063856409.1|1|1|tet(Q)|tet(Q)|target_protection|2|TETRACYCLINE|TETRACYCLINE|tetracycline_resistance_ribosomal_protection_protein_Tet(Q)|AMR|tetracycline	29.2	648	931	641	2.41e-74	256
ShaoY_2019_ERR3405992_bin.9_k141_20309_45	SARG|AAZ79478	29.2	648	931	657	3.38e-74	256
ShaoY_2019_ERR3405992_bin.9_k141_20309_45	NCBI|WP_063856408.1|1|1|tet(Q)|tet(Q)|target_protection|2|TETRACYCLINE|TETRACYCLINE|tetracycline_resistance_ribosomal_protection_protein_Tet(Q)|AMR|tetracycline	29.2	648	931	654	6.01e-74	255
ShaoY_2019_ERR3405992_bin.9_k141_20309_72	SARG|gb|MBW0770001.1|ARO:3007026|salB	25.2	409	437	541	9.57e-31	123
ShaoY_2019_ERR3405992_bin.9_k141_20309_72	SARG|U82085.gene.p01	26.7	439	437	552	3.51e-30	121
ShaoY_2019_ERR3405992_bin.9_k141_20309_72	SARG|gb|ABX00624.1|ARO:3002881|lmrC	27.5	397	437	550	2.44e-28	116
ShaoY_2019_ERR3405992_bin.9_k141_20309_72	NCBI|WP_171943877.1|1|1|vga(F)|vga(F)|target_protection|2|LINCOSAMIDE|LINCOSAMIDE|ABC-F_type_ribosomal_protection_protein_Vga(F)|AMR|lincosamide	25.7	417	437	461	4.19e-28	114
ShaoY_2019_ERR3405992_bin.9_k141_20309_72	SARG|gb|WP_096809342.1|ARO:3007029|salE	28.3	375	437	543	5.81e-28	115
ShaoY_2019_ERR3405992_bin.9_k141_20309_72	SARG|gb|AGN74946|ARO:3003749|salA	25.0	416	437	541	2.13e-26	110
ShaoY_2019_ERR3405992_bin.9_k141_20309_72	NCBI|WP_172065992.1|1|1|vga(F)|vga(F)|target_protection|2|LINCOSAMIDE|LINCOSAMIDE|ABC-F_type_ribosomal_protection_protein_Vga(F)|AMR|lincosamide	25.1	415	437	461	7.67e-26	108
ShaoY_2019_ERR3405992_bin.9_k141_20309_72	NCBI|AJP12342.1|1|1|cplR|cplR|target_protection|1|CLINDAMYCIN/LINCOMYCIN/RETAPAMULIN/VIRGINIAMYCIN|LINCOSAMIDE/PLEUROMUTILIN/STREPTOGRAMIN|ABC-F_type_ribosomal_protection_protein_CplR|AMR|multidrug	32.3	167	437	550	7.57e-17	81.6
ShaoY_2019_ERR3405992_bin.9_k141_20309_72	NCBI|AKC61310.1|1|1|cplR|cplR|target_protection|1|CLINDAMYCIN/LINCOMYCIN/RETAPAMULIN/VIRGINIAMYCIN|LINCOSAMIDE/PLEUROMUTILIN/STREPTOGRAMIN|ABC-F_type_ribosomal_protection_protein_CplR|AMR|multidrug	29.3	191	437	552	1.00e-15	78.2
ShaoY_2019_ERR3405992_bin.9_k141_20309_72	SARG|FR772051.1.gene9.p01	45.9	74	437	524	3.77e-13	70.1
ShaoY_2019_ERR3405992_bin.9_k141_20309_73	SARG|gb|AAY32951.1|ARO:3002837|lnuC	60.4	164	166	164	1.82e-71	211
ShaoY_2019_ERR3405992_bin.9_k141_20309_73	SARG|gb|ABR14060.1|ARO:3002838|lnuD	61.6	164	166	164	2.58e-71	211
ShaoY_2019_ERR3405992_bin.9_k141_20309_73	SARG|gb|ACS83559.1|ARO:3004601|LnuP	54.9	164	166	166	1.17e-65	197
ShaoY_2019_ERR3405992_bin.9_k141_20309_73	megares|MEG_3621|Drugs|MLS|Lincosamide_nucleotidyltransferases|LNUP_1	54.3	164	166	166	4.75e-65	195
ShaoY_2019_ERR3405992_bin.9_k141_20309_99	megares|MEG_5409|Drugs|beta-lactam|Penicillin_binding_protein|PBP4B_1	22.2	293	602	434	8.88e-06	47.4
ShaoY_2019_ERR3405992_bin.9_k141_20309_137	SARG|gi|671541568|ref|WP_031525212.1|	35.3	221	228	648	1.26e-37	137
ShaoY_2019_ERR3405992_bin.9_k141_20309_137	SARG|gi|445996723|ref|WP_000074578.1|	29.2	219	228	309	1.44e-23	95.1
ShaoY_2019_ERR3405992_bin.9_k141_20309_137	SARG|gi|445996722|ref|WP_000074577.1|	28.8	219	228	309	2.00e-23	94.7
ShaoY_2019_ERR3405992_bin.9_k141_20309_137	SARG|gi|445996729|ref|WP_000074584.1|	28.8	219	228	309	3.86e-23	94.0
ShaoY_2019_ERR3405992_bin.9_k141_20309_137	SARG|gi|1043490477|ref|WP_065382463.1|	28.8	219	228	309	3.86e-23	94.0
ShaoY_2019_ERR3405992_bin.9_k141_20309_137	SARG|gi|445996726|ref|WP_000074581.1|	28.8	219	228	309	3.86e-23	94.0
ShaoY_2019_ERR3405992_bin.9_k141_20309_137	SARG|gi|507054395|ref|WP_016125339.1|	28.8	219	228	309	3.86e-23	94.0
ShaoY_2019_ERR3405992_bin.9_k141_20309_137	SARG|gi|445996724|ref|WP_000074579.1|	28.3	219	228	309	5.36e-23	93.6
ShaoY_2019_ERR3405992_bin.9_k141_20309_137	SARG|gi|895808656|emb|COR83787.1|	28.8	219	228	309	5.36e-23	93.6
ShaoY_2019_ERR3405992_bin.9_k141_20309_137	SARG|gi|884875933|emb|CKG93789.1|	28.3	219	228	309	7.45e-23	93.2
ShaoY_2019_ERR3405992_bin.9_k141_20309_170	SARG|GQ205627.2.gene3.p01	39.2	102	194	216	1.51e-13	65.5
ShaoY_2019_ERR3405992_bin.9_k141_20309_170	SARG|YP_002861121	51.9	52	194	212	3.79e-13	64.3
ShaoY_2019_ERR3405992_bin.9_k141_20309_170	SARG|U19459.gene.p01	48.1	52	194	212	5.25e-13	63.9
ShaoY_2019_ERR3405992_bin.9_k141_20309_170	SARG|AF368302.1.gene3.p01	35.6	104	194	204	1.24e-12	62.8
ShaoY_2019_ERR3405992_bin.9_k141_20309_170	SARG|P50870	35.6	104	194	209	1.34e-12	62.8
ShaoY_2019_ERR3405992_bin.9_k141_20309_170	SARG|AF015628.1.gene2.p01	37.1	105	194	212	1.39e-12	62.8
ShaoY_2019_ERR3405992_bin.9_k141_20309_170	SARG|AF139725.gene.p01	40.8	71	194	214	1.98e-12	62.4
ShaoY_2019_ERR3405992_bin.9_k141_20309_170	SARG|AAF24171	40.8	71	194	214	1.98e-12	62.4
ShaoY_2019_ERR3405992_bin.9_k141_20309_170	NCBI|WP_063856931.1|1|1|vat(E)|vat(E)|acetyltransferase|2|STREPTOGRAMIN|STREPTOGRAMIN|streptogramin_A_O-acetyltransferase_Vat(E)|AMR|streptogramin	47.4	57	194	214	1.98e-12	62.4
ShaoY_2019_ERR3405992_bin.9_k141_20309_170	NCBI|WP_063856932.1|1|1|vat(E)|vat(E)|acetyltransferase|2|STREPTOGRAMIN|STREPTOGRAMIN|streptogramin_A_O-acetyltransferase_Vat(E)|AMR|streptogramin	40.8	71	194	214	1.98e-12	62.4
ShaoY_2019_ERR3405992_bin.9_k141_20376_2	SARG|DQ212986.1.gene3.p01	58.1	62	76	75	4.74e-21	77.4
ShaoY_2019_ERR3405992_bin.9_k141_20501_8	SARG|gi|851913025|ref|WP_048215946.1|	37.7	228	282	648	3.10e-31	121
ShaoY_2019_ERR3405992_bin.9_k141_20501_8	SARG|YP_002850060	37.7	228	282	648	3.10e-31	121
ShaoY_2019_ERR3405992_bin.9_k141_20501_8	SARG|gi|489930965|ref|WP_003834285.1|	37.7	228	282	648	3.10e-31	121
ShaoY_2019_ERR3405992_bin.9_k141_20501_8	SARG|gi|696368937|ref|WP_032943949.1|	37.9	227	282	648	4.22e-31	120
ShaoY_2019_ERR3405992_bin.9_k141_20501_8	SARG|gi|693054987|ref|WP_032223114.1|	40.1	207	282	648	4.22e-31	120
ShaoY_2019_ERR3405992_bin.9_k141_20501_8	SARG|gi|489936909|ref|WP_003840216.1|	37.7	228	282	648	4.22e-31	120
ShaoY_2019_ERR3405992_bin.9_k141_20501_8	SARG|gi|507079862|ref|WP_016150620.1|	37.7	228	282	648	4.22e-31	120
ShaoY_2019_ERR3405992_bin.9_k141_20501_8	SARG|gi|949791377|ref|WP_057104572.1|	37.7	228	282	648	4.22e-31	120
ShaoY_2019_ERR3405992_bin.9_k141_20501_8	SARG|gi|696361545|ref|WP_032936694.1|	37.9	227	282	648	5.75e-31	120
ShaoY_2019_ERR3405992_bin.9_k141_20501_8	SARG|gi|851922185|ref|WP_048218206.1|	37.7	228	282	648	7.83e-31	120
ShaoY_2019_ERR3405992_bin.9_k141_20501_9	SARG|gi|445996719|ref|WP_000074574.1|	29.6	226	286	309	1.48e-23	96.7
ShaoY_2019_ERR3405992_bin.9_k141_20501_9	SARG|gi|445996723|ref|WP_000074578.1|	29.2	226	286	309	2.82e-23	95.9
ShaoY_2019_ERR3405992_bin.9_k141_20501_9	SARG|gi|445996722|ref|WP_000074577.1|	28.8	226	286	309	3.90e-23	95.5
ShaoY_2019_ERR3405992_bin.9_k141_20501_9	SARG|gi|1043490477|ref|WP_065382463.1|	29.2	226	286	309	5.40e-23	95.1
ShaoY_2019_ERR3405992_bin.9_k141_20501_9	SARG|gi|445996726|ref|WP_000074581.1|	29.2	226	286	309	5.40e-23	95.1
ShaoY_2019_ERR3405992_bin.9_k141_20501_9	SARG|gi|507054395|ref|WP_016125339.1|	29.2	226	286	309	5.40e-23	95.1
ShaoY_2019_ERR3405992_bin.9_k141_20501_9	SARG|gi|445996724|ref|WP_000074579.1|	28.8	226	286	309	7.46e-23	94.7
ShaoY_2019_ERR3405992_bin.9_k141_20501_9	SARG|gi|884875933|emb|CKG93789.1|	28.3	226	286	309	1.03e-22	94.4
ShaoY_2019_ERR3405992_bin.9_k141_20501_9	SARG|gi|447057509|ref|WP_001134765.1|	28.8	226	286	309	1.03e-22	94.4
ShaoY_2019_ERR3405992_bin.9_k141_20501_9	SARG|gi|445996729|ref|WP_000074584.1|	28.8	226	286	309	1.42e-22	94.0
ShaoY_2019_ERR3405992_bin.9_k141_20501_38	NCBI|WP_109545033.1|1|1|vanY-D|vanY-D|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|transpeptidase-like_D-Ala-D-Ala_carboxypeptidase_VanY-D|AMR|glycopeptide	28.8	267	368	355	2.98e-20	89.7
ShaoY_2019_ERR3405992_bin.9_k141_20501_38	megares|MEG_7602|Drugs|Glycopeptide|VanD-type_accessory_protein|VANYD_1	28.8	267	368	355	2.98e-20	89.7
ShaoY_2019_ERR3405992_bin.9_k141_20501_38	SARG|ACM47285	28.8	267	368	363	3.23e-20	89.7
ShaoY_2019_ERR3405992_bin.9_k141_20501_38	megares|MEG_7603|Drugs|Glycopeptide|VanD-type_accessory_protein|VANYD_1	28.0	282	368	355	7.49e-20	88.6
ShaoY_2019_ERR3405992_bin.9_k141_20501_38	SARG|BAE96115	28.0	282	368	355	7.49e-20	88.6
ShaoY_2019_ERR3405992_bin.9_k141_20501_38	megares|MEG_7604|Drugs|Glycopeptide|VanD-type_accessory_protein|VANYD_2	32.1	193	368	209	6.71e-19	83.2
ShaoY_2019_ERR3405992_bin.9_k141_20501_38	NCBI|WP_063856871.1|1|1|vanY-D|vanY-D|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|transpeptidase-like_D-Ala-D-Ala_carboxypeptidase_VanY-D|AMR|glycopeptide	26.6	286	368	346	1.47e-18	84.7
ShaoY_2019_ERR3405992_bin.9_k141_20501_38	NCBI|WP_063856854.1|1|1|vanY-D|vanY-D|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|transpeptidase-like_D-Ala-D-Ala_carboxypeptidase_VanY-D|AMR|glycopeptide	27.8	281	368	356	7.34e-18	82.8
ShaoY_2019_ERR3405992_bin.9_k141_20501_38	NCBI|WP_049898469.1|1|1|vanY-D|vanY-D|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|transpeptidase-like_D-Ala-D-Ala_carboxypeptidase_VanY-D|AMR|glycopeptide	28.1	281	368	356	1.35e-17	82.0
ShaoY_2019_ERR3405992_bin.9_k141_20501_38	NCBI|WP_063856862.1|1|1|vanY-D|vanY-D|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|transpeptidase-like_D-Ala-D-Ala_carboxypeptidase_VanY-D|AMR|glycopeptide	27.8	281	368	356	3.33e-17	80.9
ShaoY_2019_ERR3405992_bin.9_k141_20501_64	NCBI|XSG12257.1|1|1|drcB|drcB||1|||daptomycin_efflux_ABC_transporter_permease_DrcB|AMR|peptide	26.3	689	680	641	7.13e-44	166
ShaoY_2019_ERR3405992_bin.9_k141_20501_65	NCBI|XSG12260.1|1|1|drcA|drcA||1|||daptomycin_efflux_ABC_transporter_ATP-binding_protein_DrcA|AMR|peptide	51.2	250	256	255	7.92e-88	260
ShaoY_2019_ERR3405992_bin.9_k141_20501_65	SARG|gi|502669352|ref|WP_012905216.1|	40.3	221	256	648	1.10e-55	187
ShaoY_2019_ERR3405992_bin.9_k141_20501_65	SARG|gi|507086196|ref|WP_016156937.1|	39.8	221	256	648	1.53e-55	187
ShaoY_2019_ERR3405992_bin.9_k141_20501_65	SARG|gi|922960663|ref|WP_053388845.1|	39.4	221	256	648	4.11e-55	186
ShaoY_2019_ERR3405992_bin.9_k141_20501_65	SARG|gi|757799695|ref|WP_043016897.1|	39.4	221	256	648	5.72e-55	186
ShaoY_2019_ERR3405992_bin.9_k141_20501_65	SARG|gi|1045891604|ref|WP_065554100.1|	39.4	221	256	648	5.72e-55	186
ShaoY_2019_ERR3405992_bin.9_k141_20501_65	SARG|gi|507082903|ref|WP_016153652.1|	39.4	221	256	648	5.72e-55	186
ShaoY_2019_ERR3405992_bin.9_k141_20501_65	SARG|gi|740856590|ref|WP_038641842.1|	39.4	221	256	648	5.72e-55	186
ShaoY_2019_ERR3405992_bin.9_k141_20501_65	SARG|gi|835233765|ref|WP_047410073.1|	39.4	221	256	648	1.11e-54	185
ShaoY_2019_ERR3405992_bin.9_k141_20501_65	SARG|gi|754951242|ref|WP_042307417.1|	39.4	221	256	648	1.11e-54	185
ShaoY_2019_ERR3405992_bin.9_k141_20501_73	SARG|NC_007622.3793623.p01	21.2	396	386	388	1.90e-09	57.8
ShaoY_2019_ERR3405992_bin.9_k141_20501_73	SARG|gi|446964073|ref|WP_001041329.1|	21.2	396	386	388	4.48e-09	56.6
ShaoY_2019_ERR3405992_bin.9_k141_20501_73	SARG|gi|446964071|ref|WP_001041327.1|	21.0	391	386	388	4.48e-09	56.6
ShaoY_2019_ERR3405992_bin.9_k141_20501_73	SARG|gi|1031779476|ref|WP_064126793.1|	20.5	391	386	388	1.06e-08	55.5
ShaoY_2019_ERR3405992_bin.9_k141_20501_73	SARG|gi|446964072|ref|WP_001041328.1|	20.5	391	386	388	1.87e-08	54.7
ShaoY_2019_ERR3405992_bin.9_k141_20501_73	SARG|gi|514074859|ref|WP_016528694.1|	20.5	391	386	388	3.30e-08	53.9
ShaoY_2019_ERR3405992_bin.9_k141_20501_73	SARG|gi|486852995|ref|WP_001622527.1|	20.5	391	386	388	5.84e-08	53.1
ShaoY_2019_ERR3405992_bin.9_k141_20501_73	SARG|AAA16158	20.5	391	386	388	5.84e-08	53.1
ShaoY_2019_ERR3405992_bin.9_k141_20501_73	SARG|gi|757462838|ref|WP_042744224.1|	20.7	391	386	388	5.84e-08	53.1
ShaoY_2019_ERR3405992_bin.9_k141_20501_73	SARG|gi|930433773|ref|WP_054194603.1|	20.5	391	386	388	7.77e-08	52.8
ShaoY_2019_ERR3405992_bin.9_k141_20501_88	NCBI|XSG12258.1|1|1|drcS|drcS||1|||daptomycin_efflux_sensor_histidine_kinase_DrcS|AMR|peptide	35.6	289	383	341	4.77e-55	183
ShaoY_2019_ERR3405992_bin.9_k141_20501_89	NCBI|XSG12259.1|1|1|drcR|drcR||1|||daptomycin_efflux_response_regulator_transcription_factor_DrcR|AMR|peptide	49.8	219	224	223	4.07e-77	230
ShaoY_2019_ERR3405992_bin.9_k141_20501_89	NCBI|WP_063856723.1|1|1|vanR-B|vanR-B|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-B|AMR|glycopeptide	31.8	220	224	219	2.52e-33	118
ShaoY_2019_ERR3405992_bin.9_k141_20501_89	NCBI|WP_002317273.1|1|1|vanR-B|vanR-B|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-B|AMR|glycopeptide	31.8	220	224	219	3.54e-33	118
ShaoY_2019_ERR3405992_bin.9_k141_20501_89	NCBI|WP_063856719.1|1|1|vanR-B|vanR-B|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-B|AMR|glycopeptide	31.8	220	224	220	3.63e-33	118
ShaoY_2019_ERR3405992_bin.9_k141_20501_89	NCBI|WP_032489743.1|1|1|vanR-B|vanR-B|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-B|AMR|glycopeptide	31.8	220	224	220	5.11e-33	117
ShaoY_2019_ERR3405992_bin.9_k141_20501_89	NCBI|WP_001280781.1|1|1|vanR-A|vanR-A|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-A|AMR|glycopeptide	30.4	227	224	231	1.03e-31	114
ShaoY_2019_ERR3405992_bin.9_k141_20501_89	SARG|ZP_02848503	31.8	220	224	221	1.14e-31	114
ShaoY_2019_ERR3405992_bin.9_k141_20501_89	NCBI|WP_063856721.1|1|1|vanR-A|vanR-A|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-A|AMR|glycopeptide	30.4	227	224	231	7.96e-31	112
ShaoY_2019_ERR3405992_bin.9_k141_20501_89	NCBI|WP_063856724.1|1|1|vanR-L|vanR-L|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-L|AMR|glycopeptide	30.8	224	224	231	2.21e-30	111
ShaoY_2019_ERR3405992_bin.9_k141_20501_89	CARD|gb|AAD51348.1|ARO:3003066|smeR	30.1	219	224	229	4.16e-30	110
ShaoY_2019_ERR3405992_bin.9_k141_20501_128	SARG|gb|ADZ12699.1|ARO:3005091|RanA	30.4	191	357	258	5.55e-23	95.5
ShaoY_2019_ERR3405992_bin.9_k141_20501_189	CARD|gb|ABD30512.1|ARO:3000839|arlS	25.8	287	346	451	1.44e-27	111
ShaoY_2019_ERR3405992_bin.9_k141_20501_189	NCBI|WP_222891058.1|1|1|vanS-P|vanS-P|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_histidine_kinase_VanS-P|AMR|glycopeptide	26.8	250	346	359	7.61e-22	94.0
ShaoY_2019_ERR3405992_bin.9_k141_20501_189	CARD|gb|AEX49906.1|ARO:3003583|basS	25.5	231	346	477	2.25e-19	87.8
ShaoY_2019_ERR3405992_bin.9_k141_20501_189	megares|MEG_7514|Drugs|Glycopeptide|VanL-type_regulator|VANSL_1	26.2	263	346	364	4.22e-16	77.4
ShaoY_2019_ERR3405992_bin.9_k141_20501_189	NCBI|WP_063856745.1|1|1|vanS-L|vanS-L|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_histidine_kinase_VanS-L|AMR|glycopeptide	26.2	263	346	364	4.22e-16	77.4
ShaoY_2019_ERR3405992_bin.9_k141_20501_190	megares|MEG_4078|Drugs|Multi-drug_resistance|Multi-drug_RND_efflux_regulator|MTRAD_1	36.5	219	224	228	4.99e-42	141
ShaoY_2019_ERR3405992_bin.9_k141_20501_190	NCBI|WP_006285581.1|1|1|vanR-F|vanR-F|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-F|AMR|glycopeptide	36.6	224	224	231	1.08e-41	140
ShaoY_2019_ERR3405992_bin.9_k141_20501_190	NCBI|WP_063856726.1|1|1|vanR-M|vanR-M|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-M|AMR|glycopeptide	37.9	224	224	232	3.12e-41	139
ShaoY_2019_ERR3405992_bin.9_k141_20501_190	NCBI|WP_063856723.1|1|1|vanR-B|vanR-B|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-B|AMR|glycopeptide	36.2	218	224	219	3.45e-40	136
ShaoY_2019_ERR3405992_bin.9_k141_20501_190	NCBI|WP_002317273.1|1|1|vanR-B|vanR-B|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-B|AMR|glycopeptide	36.2	218	224	219	4.87e-40	135
ShaoY_2019_ERR3405992_bin.9_k141_20501_190	NCBI|WP_063856719.1|1|1|vanR-B|vanR-B|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-B|AMR|glycopeptide	36.2	218	224	220	5.00e-40	135
ShaoY_2019_ERR3405992_bin.9_k141_20501_190	NCBI|WP_032489743.1|1|1|vanR-B|vanR-B|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-B|AMR|glycopeptide	36.2	218	224	220	7.06e-40	135
ShaoY_2019_ERR3405992_bin.9_k141_20501_190	CARD|gb|ATC67679.1|ARO:3000838|arlR	34.2	219	224	219	1.08e-38	132
ShaoY_2019_ERR3405992_bin.9_k141_20501_190	NCBI|WP_002368697.1|1|1|vanR-B|vanR-B|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-B|AMR|glycopeptide	35.3	218	224	220	6.88e-37	127
ShaoY_2019_ERR3405992_bin.9_k141_20501_190	NCBI|WP_063856725.1|1|1|vanR-C|vanR-C|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-C|AMR|glycopeptide	33.0	230	224	231	3.98e-35	123
ShaoY_2019_ERR3405992_bin.9_k141_20501_196	SARG|gb|CAE00499.1|ARO:3003835|cdeA	31.0	432	461	441	1.43e-60	203
ShaoY_2019_ERR3405992_bin.9_k141_20501_209	SARG|gi|686113687|ref|WP_031764317.1|	24.7	434	452	451	8.93e-38	142
ShaoY_2019_ERR3405992_bin.9_k141_20501_210	SARG|gi|313638554|gb|EFS03703.1|	25.6	442	447	453	3.04e-37	140
ShaoY_2019_ERR3405992_bin.9_k141_20501_210	SARG|gi|505177635|ref|WP_015364737.1|	24.5	436	447	451	2.78e-36	137
ShaoY_2019_ERR3405992_bin.9_k141_20501_210	SARG|gi|313614636|gb|EFR88215.1|	26.1	449	447	453	5.43e-36	137
ShaoY_2019_ERR3405992_bin.9_k141_20501_210	SARG|ZP_04679156	24.3	436	447	451	1.75e-34	132
ShaoY_2019_ERR3405992_bin.9_k141_20501_210	SARG|gi|488374619|ref|WP_002444004.1|	22.8	435	447	452	2.44e-34	132
ShaoY_2019_ERR3405992_bin.9_k141_20501_210	SARG|gb|CAE00499.1|ARO:3003835|cdeA	21.6	426	447	441	7.21e-28	114
ShaoY_2019_ERR3405992_bin.9_k141_20517_11	SARG|gi|928900436|ref|WP_053931243.1|	34.3	571	576	600	1.27e-101	318
ShaoY_2019_ERR3405992_bin.9_k141_20517_11	SARG|gi|664579989|ref|WP_031094015.1|	34.3	571	576	601	1.30e-101	318
ShaoY_2019_ERR3405992_bin.9_k141_20517_11	SARG|gi|503923650|ref|WP_014157644.1|	34.2	571	576	601	5.09e-101	317
ShaoY_2019_ERR3405992_bin.9_k141_20517_11	SARG|gi|505389066|ref|WP_015576168.1|	34.0	571	576	601	7.16e-101	317
ShaoY_2019_ERR3405992_bin.9_k141_20517_11	SARG|gi|496018010|ref|WP_008742581.1|	34.8	575	576	623	9.07e-101	317
ShaoY_2019_ERR3405992_bin.9_k141_20517_11	SARG|gi|662754041|ref|WP_030125200.1|	34.0	571	576	601	1.01e-100	316
ShaoY_2019_ERR3405992_bin.9_k141_20517_11	SARG|gi|944152509|ref|WP_055644808.1|	34.0	577	576	616	1.49e-100	316
ShaoY_2019_ERR3405992_bin.9_k141_20517_11	SARG|gi|695887424|ref|WP_032788534.1|	33.5	571	576	605	2.21e-100	315
ShaoY_2019_ERR3405992_bin.9_k141_20517_11	SARG|gi|764446018|ref|WP_044369325.1|	33.5	571	576	605	3.11e-100	315
ShaoY_2019_ERR3405992_bin.9_k141_20517_11	SARG|gi|664352659|ref|WP_030880307.1|	34.2	571	576	601	3.93e-100	315
ShaoY_2019_ERR3405992_bin.9_k141_20736_4	NCBI|WP_289811733.1|1|1|tetB(60)|tetB(60)||2|TETRACYCLINE|TETRACYCLINE|tetracycline_efflux_ABC_transporter_Tet(60)_subunit_B|AMR|tetracycline	35.1	579	587	579	7.54e-97	306
ShaoY_2019_ERR3405992_bin.9_k141_20736_4	SARG|gb|ANZ79241.1|ARO:3004036|tetB(60)	34.8	577	587	579	6.27e-95	301
ShaoY_2019_ERR3405992_bin.9_k141_20736_4	SARG|gb|AET10445.1|ARO:3004033|tetB(46)	33.7	575	587	578	3.60e-93	296
ShaoY_2019_ERR3405992_bin.9_k141_20736_4	SARG|gb|AAK76136.1|ARO:3000025|patB	30.6	579	587	588	5.74e-90	288
ShaoY_2019_ERR3405992_bin.9_k141_20736_4	SARG|gi|1045390184|ref|WP_065479071.1|	30.9	567	587	605	9.96e-88	283
ShaoY_2019_ERR3405992_bin.9_k141_20736_4	SARG|gi|517381192|ref|WP_018555350.1|	31.3	566	587	602	7.01e-87	280
ShaoY_2019_ERR3405992_bin.9_k141_20736_4	SARG|gi|648667297|ref|WP_026359044.1|	30.6	566	587	605	7.54e-87	280
ShaoY_2019_ERR3405992_bin.9_k141_20736_4	SARG|gi|695865802|ref|WP_032778631.1|	30.7	566	587	605	7.54e-87	280
ShaoY_2019_ERR3405992_bin.9_k141_20736_4	SARG|gi|764446018|ref|WP_044369325.1|	30.6	566	587	605	1.06e-86	280
ShaoY_2019_ERR3405992_bin.9_k141_20736_4	SARG|gi|664180077|ref|WP_030714054.1|	30.7	566	587	605	1.48e-86	280
ShaoY_2019_ERR3405992_bin.9_k141_20736_5	SARG|gb|ANZ79240.1|ARO:3004035|tetA(60)	30.0	609	610	579	1.45e-91	293
ShaoY_2019_ERR3405992_bin.9_k141_20736_5	SARG|gb|AET10444.1|ARO:3004032|tetA(46)	30.1	604	610	574	2.61e-85	276
ShaoY_2019_ERR3405992_bin.9_k141_20736_5	SARG|gb|AAC74000.1|ARO:3003950|msbA	28.9	558	610	582	4.26e-65	223
ShaoY_2019_ERR3405992_bin.9_k141_20736_5	SARG|gi|1045390184|ref|WP_065479071.1|	30.6	591	610	605	4.85e-65	223
ShaoY_2019_ERR3405992_bin.9_k141_20736_5	SARG|gb|AYV52072.1|ARO:3002882|lmrD	31.5	518	610	664	1.04e-64	223
ShaoY_2019_ERR3405992_bin.9_k141_20736_5	SARG|gi|928900436|ref|WP_053931243.1|	30.6	591	610	600	6.07e-64	220
ShaoY_2019_ERR3405992_bin.9_k141_20736_5	SARG|gi|664579989|ref|WP_031094015.1|	30.6	591	610	601	6.19e-64	220
ShaoY_2019_ERR3405992_bin.9_k141_20736_5	SARG|gi|664395661|ref|WP_030922045.1|	31.4	593	610	601	1.19e-63	219
ShaoY_2019_ERR3405992_bin.9_k141_20736_5	SARG|gb|AAK76136.1|ARO:3000025|patB	28.0	607	610	588	1.78e-63	218
ShaoY_2019_ERR3405992_bin.9_k141_20736_5	SARG|gi|764446018|ref|WP_044369325.1|	30.3	591	610	605	2.48e-63	218
ShaoY_2019_ERR3405992_bin.9_k141_23267_8	SARG|gi|445996710|ref|WP_000074565.1|	44.7	208	215	309	7.54e-52	168
ShaoY_2019_ERR3405992_bin.9_k141_23267_8	SARG|gi|445996719|ref|WP_000074574.1|	44.7	208	215	309	2.12e-51	167
ShaoY_2019_ERR3405992_bin.9_k141_23267_8	SARG|gi|446026113|ref|WP_000103968.1|	44.1	211	215	306	5.51e-51	166
ShaoY_2019_ERR3405992_bin.9_k141_23267_8	SARG|gi|814314593|emb|CKF49145.1|	44.2	208	215	309	5.96e-51	166
ShaoY_2019_ERR3405992_bin.9_k141_23267_8	SARG|YP_001373621	44.2	208	215	318	7.52e-51	166
ShaoY_2019_ERR3405992_bin.9_k141_23267_8	SARG|gi|445996709|ref|WP_000074564.1|	44.2	208	215	309	8.41e-51	166
ShaoY_2019_ERR3405992_bin.9_k141_23267_8	SARG|gi|445996724|ref|WP_000074579.1|	44.7	208	215	309	8.41e-51	166
ShaoY_2019_ERR3405992_bin.9_k141_23267_8	SARG|gi|1043490477|ref|WP_065382463.1|	44.2	208	215	309	1.19e-50	165
ShaoY_2019_ERR3405992_bin.9_k141_23267_8	SARG|gi|445996726|ref|WP_000074581.1|	44.2	208	215	309	1.19e-50	165
ShaoY_2019_ERR3405992_bin.9_k141_23267_8	SARG|gi|884875933|emb|CKG93789.1|	44.7	208	215	309	1.19e-50	165
ShaoY_2019_ERR3405992_bin.9_k141_23267_31	SARG|gb|AAK76136.1|ARO:3000025|patB	31.1	604	631	588	1.99e-93	298
ShaoY_2019_ERR3405992_bin.9_k141_23267_31	SARG|gb|AYV52072.1|ARO:3002882|lmrD	29.8	588	631	664	4.79e-86	281
ShaoY_2019_ERR3405992_bin.9_k141_23267_31	SARG|gi|497748188|ref|WP_010062372.1|	29.5	607	631	605	6.79e-76	253
ShaoY_2019_ERR3405992_bin.9_k141_23267_31	SARG|gi|695887424|ref|WP_032788534.1|	29.3	604	631	605	1.32e-75	252
ShaoY_2019_ERR3405992_bin.9_k141_23267_31	SARG|gb|CDO61516.1|ARO:3003949|efrB	37.6	364	631	362	2.01e-75	244
ShaoY_2019_ERR3405992_bin.9_k141_23267_31	SARG|gi|951183771|ref|WP_057661487.1|	29.7	607	631	603	3.43e-75	251
ShaoY_2019_ERR3405992_bin.9_k141_23267_31	SARG|gb|AET10445.1|ARO:3004033|tetB(46)	29.6	597	631	578	3.79e-75	250
ShaoY_2019_ERR3405992_bin.9_k141_23267_31	SARG|gi|764446018|ref|WP_044369325.1|	29.2	607	631	605	4.99e-75	250
ShaoY_2019_ERR3405992_bin.9_k141_23267_31	SARG|gi|664180077|ref|WP_030714054.1|	29.1	604	631	605	4.99e-75	250
ShaoY_2019_ERR3405992_bin.9_k141_23267_31	SARG|gi|944009777|ref|WP_055601444.1|	30.4	625	631	628	5.90e-75	251
ShaoY_2019_ERR3405992_bin.9_k141_23267_32	SARG|gb|AAK76137.1|ARO:3000024|patA	35.2	571	583	564	2.96e-98	309
ShaoY_2019_ERR3405992_bin.9_k141_23267_32	SARG|gb|WP_104671188.1|ARO:3003948|efrA	34.3	548	583	575	7.86e-98	308
ShaoY_2019_ERR3405992_bin.9_k141_23267_32	SARG|gb|AAK76136.1|ARO:3000025|patB	27.9	519	583	588	5.16e-61	211
ShaoY_2019_ERR3405992_bin.9_k141_23267_32	SARG|gi|1045390184|ref|WP_065479071.1|	29.4	528	583	605	6.96e-60	208
ShaoY_2019_ERR3405992_bin.9_k141_23267_32	SARG|gb|AYV52072.1|ARO:3002882|lmrD	29.9	465	583	664	1.36e-59	209
ShaoY_2019_ERR3405992_bin.9_k141_23267_32	SARG|gi|497748188|ref|WP_010062372.1|	29.2	528	583	605	6.81e-59	206
ShaoY_2019_ERR3405992_bin.9_k141_23267_32	SARG|gi|764446018|ref|WP_044369325.1|	29.2	528	583	605	2.50e-58	204
ShaoY_2019_ERR3405992_bin.9_k141_23267_32	SARG|gi|695842130|ref|WP_032755430.1|	28.8	528	583	603	3.34e-58	204
ShaoY_2019_ERR3405992_bin.9_k141_23267_32	SARG|gi|501350226|ref|WP_012381861.1|	28.8	528	583	603	4.63e-58	203
ShaoY_2019_ERR3405992_bin.9_k141_23267_32	SARG|gi|695865802|ref|WP_032778631.1|	29.0	528	583	605	4.79e-58	203
ShaoY_2019_ERR3405992_bin.9_k141_23267_45	SARG|gi|851922185|ref|WP_048218206.1|	52.8	218	235	648	1.76e-74	236
ShaoY_2019_ERR3405992_bin.9_k141_23267_45	SARG|gi|949718947|ref|WP_057063453.1|	52.8	218	235	648	1.76e-74	236
ShaoY_2019_ERR3405992_bin.9_k141_23267_45	SARG|gi|696375069|ref|WP_032949617.1|	52.8	218	235	648	1.76e-74	236
ShaoY_2019_ERR3405992_bin.9_k141_23267_45	SARG|gi|489127020|ref|WP_003036815.1|	52.8	218	235	648	1.76e-74	236
ShaoY_2019_ERR3405992_bin.9_k141_23267_45	SARG|gi|696368937|ref|WP_032943949.1|	52.8	218	235	648	3.47e-74	236
ShaoY_2019_ERR3405992_bin.9_k141_23267_45	SARG|gi|851913025|ref|WP_048215946.1|	52.8	218	235	648	3.47e-74	236
ShaoY_2019_ERR3405992_bin.9_k141_23267_45	SARG|gi|489930965|ref|WP_003834285.1|	52.8	218	235	648	3.47e-74	236
ShaoY_2019_ERR3405992_bin.9_k141_23267_45	SARG|gi|696361545|ref|WP_032936694.1|	52.8	218	235	648	4.86e-74	235
ShaoY_2019_ERR3405992_bin.9_k141_23267_45	SARG|gi|489936909|ref|WP_003840216.1|	52.8	218	235	648	4.86e-74	235
ShaoY_2019_ERR3405992_bin.9_k141_23267_45	SARG|gi|507079862|ref|WP_016150620.1|	52.8	218	235	648	4.86e-74	235
ShaoY_2019_ERR3405992_bin.9_k141_23267_47	SARG|gb|AAV85982.1|ARO:3000535|macB	33.9	425	420	644	2.44e-51	181
ShaoY_2019_ERR3405992_bin.9_k141_23267_47	SARG|gi|1035670474|ref|WP_064517458.1|	31.8	424	420	648	3.78e-42	156
ShaoY_2019_ERR3405992_bin.9_k141_23267_47	SARG|gi|1035717981|ref|WP_064557480.1|	31.8	424	420	648	3.78e-42	156
ShaoY_2019_ERR3405992_bin.9_k141_23267_47	SARG|gi|657888313|ref|WP_029592374.1|	31.2	423	420	648	1.83e-41	154
ShaoY_2019_ERR3405992_bin.9_k141_23267_47	SARG|gi|639218559|ref|WP_024556062.1|	31.2	423	420	648	2.51e-41	154
ShaoY_2019_ERR3405992_bin.9_k141_23267_47	SARG|gi|506220920|ref|WP_015740695.1|	31.4	421	420	647	4.66e-41	153
ShaoY_2019_ERR3405992_bin.9_k141_23267_47	SARG|gi|495067432|ref|WP_007792257.1|	30.6	421	420	647	4.66e-41	153
ShaoY_2019_ERR3405992_bin.9_k141_23267_47	SARG|gi|736472622|ref|WP_034494292.1|	31.1	424	420	648	4.70e-41	153
ShaoY_2019_ERR3405992_bin.9_k141_23267_47	SARG|gi|696411918|ref|WP_032982657.1|	30.6	421	420	647	8.74e-41	152
ShaoY_2019_ERR3405992_bin.9_k141_23267_47	SARG|gi|696402390|ref|WP_032974230.1|	30.6	421	420	647	8.74e-41	152
ShaoY_2019_ERR3405992_bin.9_k141_23267_150	SARG|gi|489117806|ref|WP_003027650.1|	30.4	316	311	660	6.38e-47	166
ShaoY_2019_ERR3405992_bin.9_k141_23267_150	SARG|gi|507086291|ref|WP_016157032.1|	30.7	316	311	660	8.80e-47	166
ShaoY_2019_ERR3405992_bin.9_k141_23267_150	SARG|gi|696375142|ref|WP_032949690.1|	30.4	316	311	660	8.80e-47	166
ShaoY_2019_ERR3405992_bin.9_k141_23267_150	SARG|gi|765458296|ref|WP_044714032.1|	30.4	316	311	660	1.22e-46	165
ShaoY_2019_ERR3405992_bin.9_k141_23267_150	SARG|gi|489931383|ref|WP_003834702.1|	30.4	316	311	660	1.68e-46	165
ShaoY_2019_ERR3405992_bin.9_k141_23267_150	SARG|gi|851965596|ref|WP_048234849.1|	30.1	316	311	660	6.09e-46	163
ShaoY_2019_ERR3405992_bin.9_k141_23267_150	SARG|gi|507083067|ref|WP_016153816.1|	30.4	316	311	660	8.40e-46	163
ShaoY_2019_ERR3405992_bin.9_k141_23267_150	SARG|gi|507079934|ref|WP_016150692.1|	30.1	316	311	660	1.16e-45	162
ShaoY_2019_ERR3405992_bin.9_k141_23267_150	SARG|gi|851917461|ref|WP_048217311.1|	30.1	316	311	660	1.16e-45	162
ShaoY_2019_ERR3405992_bin.9_k141_23267_150	SARG|gi|851981245|ref|WP_048240645.1|	30.1	316	311	660	1.16e-45	162
ShaoY_2019_ERR3405992_bin.9_k141_23267_153	SARG|AXY65402.1	34.9	324	355	357	2.62e-49	168
ShaoY_2019_ERR3405992_bin.9_k141_23267_155	CARD|gb|WKR28567.1|ARO:3007678|IreK	43.4	320	719	718	6.70e-80	268
ShaoY_2019_ERR3405992_bin.9_k141_23267_166	SARG|gb|WP_104671188.1|ARO:3003948|efrA	39.1	578	583	575	9.95e-121	367
ShaoY_2019_ERR3405992_bin.9_k141_23267_166	SARG|gb|AAK76137.1|ARO:3000024|patA	32.3	576	583	564	1.63e-88	283
ShaoY_2019_ERR3405992_bin.9_k141_23267_166	SARG|gb|ANZ79241.1|ARO:3004036|tetB(60)	27.6	579	583	579	8.28e-60	207
ShaoY_2019_ERR3405992_bin.9_k141_23267_166	NCBI|WP_289811733.1|1|1|tetB(60)|tetB(60)||2|TETRACYCLINE|TETRACYCLINE|tetracycline_efflux_ABC_transporter_Tet(60)_subunit_B|AMR|tetracycline	27.1	580	583	579	8.15e-59	205
ShaoY_2019_ERR3405992_bin.9_k141_23267_166	SARG|gb|AET10444.1|ARO:3004032|tetA(46)	27.6	561	583	574	1.98e-58	204
ShaoY_2019_ERR3405992_bin.9_k141_23267_166	SARG|gb|AYV52072.1|ARO:3002882|lmrD	26.4	535	583	664	3.80e-54	194
ShaoY_2019_ERR3405992_bin.9_k141_23267_166	SARG|gi|655413091|ref|WP_028811890.1|	38.8	289	583	603	1.44e-53	191
ShaoY_2019_ERR3405992_bin.9_k141_23267_166	NCBI|WP_289811734.1|1|1|tetA(60)|tetA(60)||2|TETRACYCLINE|TETRACYCLINE|tetracycline_efflux_ABC_transporter_Tet(60)_subunit_A|AMR|tetracycline	32.1	386	583	579	1.86e-53	190
ShaoY_2019_ERR3405992_bin.9_k141_23267_166	SARG|gb|ANZ79240.1|ARO:3004035|tetA(60)	31.9	389	583	579	2.56e-53	190
ShaoY_2019_ERR3405992_bin.9_k141_23267_166	SARG|gi|917203192|ref|WP_051809904.1|	37.4	297	583	620	9.35e-53	189
ShaoY_2019_ERR3405992_bin.9_k141_23267_167	SARG|gb|AAK76136.1|ARO:3000025|patB	34.2	552	585	588	1.67e-105	328
ShaoY_2019_ERR3405992_bin.9_k141_23267_167	SARG|gb|AYV52072.1|ARO:3002882|lmrD	37.6	500	585	664	2.88e-102	322
ShaoY_2019_ERR3405992_bin.9_k141_23267_167	SARG|gb|CDO61516.1|ARO:3003949|efrB	46.4	323	585	362	5.42e-91	283
ShaoY_2019_ERR3405992_bin.9_k141_23267_167	SARG|gi|496018010|ref|WP_008742581.1|	31.9	540	585	623	5.94e-86	278
ShaoY_2019_ERR3405992_bin.9_k141_23267_167	SARG|gi|917203192|ref|WP_051809904.1|	32.4	546	585	620	1.09e-85	278
ShaoY_2019_ERR3405992_bin.9_k141_23267_167	SARG|gi|860594225|ref|WP_048475168.1|	31.2	542	585	620	2.13e-85	277
ShaoY_2019_ERR3405992_bin.9_k141_23267_167	SARG|gi|926294973|ref|WP_053631154.1|	32.1	546	585	620	2.98e-85	276
ShaoY_2019_ERR3405992_bin.9_k141_23267_167	SARG|gi|926356413|ref|WP_053687351.1|	32.1	546	585	620	4.17e-85	276
ShaoY_2019_ERR3405992_bin.9_k141_23267_167	SARG|gi|799286378|ref|WP_045936958.1|	32.1	546	585	620	4.17e-85	276
ShaoY_2019_ERR3405992_bin.9_k141_23267_167	SARG|gi|917127754|ref|WP_051734466.1|	32.1	546	585	620	4.17e-85	276
ShaoY_2019_ERR3405992_bin.9_k141_26138_31	NCBI|AKA30736.1|1|1|cxpE|cxpE||1|CHLORAMPHENICOL|PHENICOL|phenicol_efflux_transporter_CxpE|AMR|phenicol	29.0	186	438	397	4.34e-17	81.6
ShaoY_2019_ERR3405992_bin.9_k141_26138_33	NCBI|WP_063856748.1|1|1|vanS-M|vanS-M|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_histidine_kinase_VanS-M|AMR|glycopeptide	31.8	236	458	370	3.09e-25	105
ShaoY_2019_ERR3405992_bin.9_k141_26138_33	megares|MEG_7505|Drugs|Glycopeptide|VanD-type_regulator|VANSD_1	28.2	248	458	381	4.85e-25	105
ShaoY_2019_ERR3405992_bin.9_k141_26138_33	NCBI|WP_063856730.1|1|1|vanS-D|vanS-D|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_histidine_kinase_VanS-D|AMR|glycopeptide	28.2	248	458	381	4.85e-25	105
ShaoY_2019_ERR3405992_bin.9_k141_26138_33	NCBI|WP_028530133.1|1|1|vanS-D|vanS-D|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_histidine_kinase_VanS-D|AMR|glycopeptide	27.8	248	458	381	8.96e-25	104
ShaoY_2019_ERR3405992_bin.9_k141_26138_33	megares|MEG_7506|Drugs|Glycopeptide|VanD-type_regulator|VANSD_1	27.8	248	458	381	8.96e-25	104
ShaoY_2019_ERR3405992_bin.9_k141_26138_33	NCBI|WP_023042297.1|1|1|vanS-D|vanS-D|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_histidine_kinase_VanS-D|AMR|glycopeptide	27.9	244	458	381	1.22e-24	103
ShaoY_2019_ERR3405992_bin.9_k141_26138_33	megares|MEG_7509|Drugs|Glycopeptide|VanD-type_regulator|VANSD_1	27.9	244	458	381	1.22e-24	103
ShaoY_2019_ERR3405992_bin.9_k141_26138_33	NCBI|WP_063856732.1|1|1|vanS-G|vanS-G|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_histidine_kinase_VanS-G|AMR|glycopeptide	27.3	282	458	367	3.49e-24	102
ShaoY_2019_ERR3405992_bin.9_k141_26138_33	NCBI|WP_021418927.1|1|1|vanS-G|vanS-G|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_histidine_kinase_VanS-G|AMR|glycopeptide	27.3	282	458	368	3.53e-24	102
ShaoY_2019_ERR3405992_bin.9_k141_26138_33	NCBI|WP_006285582.1|1|1|vanS-F|vanS-F|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_histidine_kinase_VanS-F|AMR|glycopeptide	29.8	242	458	365	5.34e-23	99.0
ShaoY_2019_ERR3405992_bin.9_k141_26138_34	NCBI|WP_021418928.1|1|1|vanR-G|vanR-G|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-G|AMR|glycopeptide	48.1	231	231	235	1.56e-76	229
ShaoY_2019_ERR3405992_bin.9_k141_26138_34	NCBI|AXB64454.1|1|1|vanR-Cd|vanR-Cd|re-structuring_of_the_cell_wall|1|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-G-Cd|AMR|glycopeptide	46.9	228	231	233	1.37e-74	224
ShaoY_2019_ERR3405992_bin.9_k141_26138_34	NCBI|WP_006285581.1|1|1|vanR-F|vanR-F|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-F|AMR|glycopeptide	46.2	225	231	231	1.47e-73	222
ShaoY_2019_ERR3405992_bin.9_k141_26138_34	NCBI|WP_063856718.1|1|1|vanR-E|vanR-E|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-E|AMR|glycopeptide	46.2	225	231	229	4.52e-72	218
ShaoY_2019_ERR3405992_bin.9_k141_26138_34	NCBI|WP_011461303.1|1|1|vanR-I|vanR-I|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-I|AMR|glycopeptide	45.4	227	231	232	7.06e-72	218
ShaoY_2019_ERR3405992_bin.9_k141_26138_34	megares|MEG_7482|Drugs|Glycopeptide|VanL-type_regulator|VANRI_1	45.4	227	231	232	7.06e-72	218
ShaoY_2019_ERR3405992_bin.9_k141_26138_34	NCBI|WP_003126775.1|1|1|vanR-C|vanR-C|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-C|AMR|glycopeptide	46.0	226	231	231	5.54e-71	215
ShaoY_2019_ERR3405992_bin.9_k141_26138_34	NCBI|WP_222891057.1|1|1|vanR-P|vanR-P|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-P|AMR|glycopeptide	45.7	230	231	239	1.01e-70	215
ShaoY_2019_ERR3405992_bin.9_k141_26138_34	NCBI|WP_063856726.1|1|1|vanR-M|vanR-M|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-M|AMR|glycopeptide	45.3	225	231	232	2.31e-70	214
ShaoY_2019_ERR3405992_bin.9_k141_26138_34	NCBI|WP_005228837.1|1|1|vanR-C|vanR-C|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-C|AMR|glycopeptide	46.3	227	231	231	6.36e-70	213
ShaoY_2019_ERR3405992_bin.9_k141_29202_23	CARD|gb|BAB80490.1|ARO:3007644|Cper_cplR	27.1	218	371	568	2.49e-12	67.0
ShaoY_2019_ERR3405992_bin.9_k141_29202_23	NCBI|AJP12342.1|1|1|cplR|cplR|target_protection|1|CLINDAMYCIN/LINCOMYCIN/RETAPAMULIN/VIRGINIAMYCIN|LINCOSAMIDE/PLEUROMUTILIN/STREPTOGRAMIN|ABC-F_type_ribosomal_protection_protein_CplR|AMR|multidrug	23.9	226	371	550	4.16e-10	60.1
ShaoY_2019_ERR3405992_bin.9_k141_29202_23	SARG|gi|686436876|ref|WP_031922735.1|	23.3	210	371	491	2.83e-09	57.4
ShaoY_2019_ERR3405992_bin.9_k141_29202_23	SARG|gi|686444151|ref|WP_031925491.1|	22.9	210	371	488	3.63e-08	53.9
ShaoY_2019_ERR3405992_bin.9_k141_29202_23	SARG|gi|581672381|gb|EVQ77821.1|	22.4	210	371	394	4.12e-08	53.5
ShaoY_2019_ERR3405992_bin.9_k141_29202_23	SARG|gi|587321226|gb|EWW03298.1|	22.4	210	371	413	4.29e-08	53.5
ShaoY_2019_ERR3405992_bin.9_k141_29202_23	SARG|gi|580336413|gb|EVD62957.1|	22.4	210	371	478	4.76e-08	53.5
ShaoY_2019_ERR3405992_bin.9_k141_29202_23	SARG|YP_001569068	22.4	210	371	488	4.82e-08	53.5
ShaoY_2019_ERR3405992_bin.9_k141_29202_23	SARG|gi|686379454|ref|WP_031899389.1|	22.4	210	371	488	4.82e-08	53.5
ShaoY_2019_ERR3405992_bin.9_k141_29202_23	SARG|gi|727749040|ref|WP_033861720.1|	22.4	210	371	488	4.82e-08	53.5
ShaoY_2019_ERR3405992_bin.9_k141_29202_64	SARG|P42332	28.6	290	288	306	3.98e-30	114
ShaoY_2019_ERR3405992_bin.9_k141_29202_64	SARG|gi|447195835|ref|WP_001273091.1|	33.2	211	288	306	3.98e-30	114
ShaoY_2019_ERR3405992_bin.9_k141_29202_64	megares|MEG_1213|Drugs|Bacitracin|Bacitracin_ABC_transporter|BCRA_1	28.6	290	288	306	3.98e-30	114
ShaoY_2019_ERR3405992_bin.9_k141_29202_64	SARG|gi|510143239|gb|AGN36970.1|	28.6	290	288	313	4.55e-30	114
ShaoY_2019_ERR3405992_bin.9_k141_29202_64	SARG|ABB80128	28.6	290	288	306	5.55e-30	114
ShaoY_2019_ERR3405992_bin.9_k141_29202_64	SARG|ZP_04081918	32.7	211	288	306	7.74e-30	113
ShaoY_2019_ERR3405992_bin.9_k141_29202_64	SARG|gi|447195836|ref|WP_001273092.1|	32.7	211	288	306	1.08e-29	113
ShaoY_2019_ERR3405992_bin.9_k141_29202_64	SARG|gi|542061059|gb|ERI11611.1|	32.2	211	288	316	1.81e-29	112
ShaoY_2019_ERR3405992_bin.9_k141_29202_64	SARG|gi|446026113|ref|WP_000103968.1|	31.4	207	288	306	4.06e-29	111
ShaoY_2019_ERR3405992_bin.9_k141_29202_64	SARG|gi|500448961|gb|EOP61695.1|	31.1	212	288	306	1.53e-28	110
ShaoY_2019_ERR3405992_bin.9_k141_29202_74	SARG|YP_002333394	34.7	118	388	323	2.45e-12	66.2
ShaoY_2019_ERR3405992_bin.9_k141_29202_74	SARG|AF310956.2.gene5.p01	33.9	118	388	323	7.93e-12	64.7
ShaoY_2019_ERR3405992_bin.9_k141_29202_74	NCBI|WP_063856701.1|1|1|vanH-B|vanH-B|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|D-lactate_dehydrogenase_VanH-B|AMR|glycopeptide	33.9	118	388	323	7.93e-12	64.7
ShaoY_2019_ERR3405992_bin.9_k141_29202_74	SARG|gb|AAB05626.1|ARO:3002943|vanHB	33.1	118	388	323	1.42e-11	63.9
ShaoY_2019_ERR3405992_bin.9_k141_29202_74	SARG|Q47748	33.1	118	388	323	2.56e-11	63.2
ShaoY_2019_ERR3405992_bin.9_k141_29202_74	SARG|gi|498515089|ref|WP_010815296.1|	33.1	118	388	323	4.58e-11	62.4
ShaoY_2019_ERR3405992_bin.9_k141_29202_74	SARG|gi|985522333|ref|WP_060811962.1|	33.1	118	388	323	6.14e-11	62.0
ShaoY_2019_ERR3405992_bin.9_k141_29202_87	SARG|YP_002937728	98.6	289	290	289	2.51e-199	545
ShaoY_2019_ERR3405992_bin.9_k141_29202_87	SARG|ZP_03958019	66.1	280	290	317	2.25e-125	359
ShaoY_2019_ERR3405992_bin.9_k141_29202_87	SARG|ZP_04528247	63.5	285	290	279	6.48e-116	333
ShaoY_2019_ERR3405992_bin.9_k141_29202_87	SARG|YP_002929946	58.2	282	290	282	1.06e-105	308
ShaoY_2019_ERR3405992_bin.9_k141_29202_87	SARG|ZP_03984017	55.6	277	290	288	1.86e-95	282
ShaoY_2019_ERR3405992_bin.9_k141_29202_87	SARG|ZP_04433866	55.2	277	290	288	3.74e-95	281
ShaoY_2019_ERR3405992_bin.9_k141_29202_87	SARG|ZP_03949893	55.2	277	290	288	3.74e-95	281
ShaoY_2019_ERR3405992_bin.9_k141_29202_87	SARG|ZP_03941859	50.0	280	290	288	1.68e-83	251
ShaoY_2019_ERR3405992_bin.9_k141_29202_87	SARG|ZP_03938934	50.0	280	290	288	1.68e-83	251
ShaoY_2019_ERR3405992_bin.9_k141_29202_87	SARG|ZP_03916453	47.0	287	290	290	1.07e-79	242
ShaoY_2019_ERR3405992_bin.9_k141_29496_2	SARG|gb|MBY8651254.1|ARO:3007188|vanH_in_vanP_cl	29.0	248	312	314	3.00e-28	110
ShaoY_2019_ERR3405992_bin.9_k141_29496_2	NCBI|WP_063856705.1|1|1|vanH-D|vanH-D|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|D-lactate_dehydrogenase_VanH-D|AMR|glycopeptide	30.2	255	312	323	3.51e-28	110
ShaoY_2019_ERR3405992_bin.9_k141_29496_2	SARG|DQ018711.1.gene4.p01	31.8	261	312	322	2.46e-27	107
ShaoY_2019_ERR3405992_bin.9_k141_29496_2	SARG|gi|738848198|ref|WP_036737307.1|	31.4	261	312	323	3.39e-26	104
ShaoY_2019_ERR3405992_bin.9_k141_29496_2	SARG|gi|737310392|ref|WP_035293250.1|	31.0	261	312	323	3.28e-25	102
ShaoY_2019_ERR3405992_bin.9_k141_29496_2	SARG|FJ349556.1.gene5.p01	31.2	237	312	326	3.44e-25	102
ShaoY_2019_ERR3405992_bin.9_k141_29496_2	SARG|AAR37059	30.9	256	312	323	6.28e-25	101
ShaoY_2019_ERR3405992_bin.9_k141_29496_2	SARG|AAD41881	30.9	256	312	323	6.28e-25	101
ShaoY_2019_ERR3405992_bin.9_k141_29496_2	SARG|gi|740152780|ref|WP_037997109.1|	28.8	260	312	322	1.63e-24	100
ShaoY_2019_ERR3405992_bin.9_k141_29496_2	SARG|AAD51059	30.5	256	312	323	2.28e-24	99.8
ShaoY_2019_ERR3405992_bin.9_k141_29496_11	NCBI|XSG12260.1|1|1|drcA|drcA||1|||daptomycin_efflux_ABC_transporter_ATP-binding_protein_DrcA|AMR|peptide	32.9	210	221	255	1.30e-34	122
ShaoY_2019_ERR3405992_bin.9_k141_29496_11	SARG|AAA50325	29.2	209	221	569	1.93e-12	64.7
ShaoY_2019_ERR3405992_bin.9_k141_29496_11	NCBI|AKC61310.1|1|1|cplR|cplR|target_protection|1|CLINDAMYCIN/LINCOMYCIN/RETAPAMULIN/VIRGINIAMYCIN|LINCOSAMIDE/PLEUROMUTILIN/STREPTOGRAMIN|ABC-F_type_ribosomal_protection_protein_CplR|AMR|multidrug	32.4	74	221	552	1.75e-06	47.0
ShaoY_2019_ERR3405992_bin.9_k141_29496_11	SARG|gb|AEO25219.1|ARO:3004651|lin	23.5	166	221	523	4.17e-06	45.8
ShaoY_2019_ERR3405992_bin.9_k141_29496_13	NCBI|WP_006285581.1|1|1|vanR-F|vanR-F|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-F|AMR|glycopeptide	41.0	229	232	231	1.05e-55	176
ShaoY_2019_ERR3405992_bin.9_k141_29496_13	NCBI|WP_011461303.1|1|1|vanR-I|vanR-I|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-I|AMR|glycopeptide	37.8	230	232	232	1.98e-53	171
ShaoY_2019_ERR3405992_bin.9_k141_29496_13	megares|MEG_7482|Drugs|Glycopeptide|VanL-type_regulator|VANRI_1	37.8	230	232	232	1.98e-53	171
ShaoY_2019_ERR3405992_bin.9_k141_29496_13	NCBI|WP_063856718.1|1|1|vanR-E|vanR-E|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-E|AMR|glycopeptide	38.2	233	232	229	9.27e-51	164
ShaoY_2019_ERR3405992_bin.9_k141_29496_13	NCBI|WP_063856726.1|1|1|vanR-M|vanR-M|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-M|AMR|glycopeptide	38.9	229	232	232	4.04e-50	162
ShaoY_2019_ERR3405992_bin.9_k141_29496_13	NCBI|WP_063856721.1|1|1|vanR-A|vanR-A|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-A|AMR|glycopeptide	36.2	232	232	231	7.85e-50	161
ShaoY_2019_ERR3405992_bin.9_k141_29496_13	NCBI|WP_001280781.1|1|1|vanR-A|vanR-A|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-A|AMR|glycopeptide	35.3	232	232	231	1.11e-49	161
ShaoY_2019_ERR3405992_bin.9_k141_29496_13	NCBI|WP_063856720.1|1|1|vanR-A|vanR-A|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-A|AMR|glycopeptide	36.6	232	232	231	4.43e-49	159
ShaoY_2019_ERR3405992_bin.9_k141_29496_13	megares|MEG_7449|Drugs|Glycopeptide|VanA-type_regulator|VANRA_1	35.8	232	232	231	1.25e-48	158
ShaoY_2019_ERR3405992_bin.9_k141_29496_13	NCBI|WP_063856716.1|1|1|vanR-A|vanR-A|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-A|AMR|glycopeptide	35.8	232	232	231	1.25e-48	158
ShaoY_2019_ERR3405992_bin.9_k141_29496_14	NCBI|WP_063856748.1|1|1|vanS-M|vanS-M|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_histidine_kinase_VanS-M|AMR|glycopeptide	24.8	145	377	370	1.63e-06	48.5
ShaoY_2019_ERR3405992_bin.9_k141_29496_22	CARD|gb|BAD59497.1|ARO:3000501|rpoB2	52.6	1244	1314	1162	0.0	1184
ShaoY_2019_ERR3405992_bin.9_k141_29496_22	CARD|gb|WP_041777404.1|ARO:3004480|Bado_rpoB_RIF	50.4	1251	1314	1186	0.0	1116
ShaoY_2019_ERR3405992_bin.9_k141_29496_22	megares|MEG_8674|Drugs|Rifampin|Rifampin-resistant_beta-subunit_of_RNA_polymerase_RpoB|RPOB_1	50.4	1251	1314	1186	0.0	1116
ShaoY_2019_ERR3405992_bin.9_k141_29496_26	SARG|L42544.gene.p01	28.8	694	706	651	2.49e-74	251
ShaoY_2019_ERR3405992_bin.9_k141_29496_26	SARG|AAV80410	28.8	694	706	651	4.80e-74	251
ShaoY_2019_ERR3405992_bin.9_k141_29496_26	SARG|NP_348076	27.5	684	706	652	6.80e-74	250
ShaoY_2019_ERR3405992_bin.9_k141_29496_26	SARG|YP_002850805	27.4	682	706	652	2.47e-71	243
ShaoY_2019_ERR3405992_bin.9_k141_29496_26	SARG|ZP_02952732	27.3	682	706	652	8.97e-70	239
ShaoY_2019_ERR3405992_bin.9_k141_29496_26	SARG|ZP_02632674	27.3	682	706	660	1.05e-69	239
ShaoY_2019_ERR3405992_bin.9_k141_29496_26	SARG|L20800.gene.p01	27.3	682	706	652	3.30e-69	238
ShaoY_2019_ERR3405992_bin.9_k141_29496_26	SARG|AJ514254.gene.p01	26.9	694	706	640	1.22e-65	228
ShaoY_2019_ERR3405992_bin.9_k141_29496_26	megares|MEG_7175|Drugs|Tetracycline|Tetracycline_resistance_ribosomal_protection_proteins|TETO_1	27.1	682	706	639	1.06e-62	219
ShaoY_2019_ERR3405992_bin.9_k141_29496_26	SARG|AAO42740	26.7	682	706	639	1.23e-59	211
ShaoY_2019_ERR3405992_bin.9_k141_29496_27	NCBI|WP_050824634.1|1|1|tet(O)|tet(O)|target_protection|2|TETRACYCLINE|TETRACYCLINE|tetracycline_resistance_ribosomal_protection_protein_Tet(O)|AMR|tetracycline	34.4	154	396	639	1.43e-15	77.4
ShaoY_2019_ERR3405992_bin.9_k141_29496_27	SARG|ACF08831	35.8	134	396	639	1.91e-15	77.0
ShaoY_2019_ERR3405992_bin.9_k141_29496_37	ResF|mdt(A)_1_X92946_1	19.5	293	420	418	4.15e-08	53.9
ShaoY_2019_ERR3405992_bin.9_k141_29496_52	SARG|gb|APB03216.1|ARO:3003982|LlmA	59.7	295	295	287	2.82e-132	375
ShaoY_2019_ERR3405992_bin.9_k141_29496_99	NCBI|WP_006285581.1|1|1|vanR-F|vanR-F|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-F|AMR|glycopeptide	44.6	224	230	231	5.58e-63	195
ShaoY_2019_ERR3405992_bin.9_k141_29496_99	CARD|gb|ATC67679.1|ARO:3000838|arlR	44.4	225	230	219	3.55e-61	190
ShaoY_2019_ERR3405992_bin.9_k141_29496_99	NCBI|WP_011461303.1|1|1|vanR-I|vanR-I|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-I|AMR|glycopeptide	43.9	230	230	232	4.27e-60	187
ShaoY_2019_ERR3405992_bin.9_k141_29496_99	megares|MEG_7482|Drugs|Glycopeptide|VanL-type_regulator|VANRI_1	43.9	230	230	232	4.27e-60	187
ShaoY_2019_ERR3405992_bin.9_k141_29496_99	NCBI|AXB64454.1|1|1|vanR-Cd|vanR-Cd|re-structuring_of_the_cell_wall|1|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-G-Cd|AMR|glycopeptide	45.8	225	230	233	4.40e-60	187
ShaoY_2019_ERR3405992_bin.9_k141_29496_99	NCBI|WP_005228837.1|1|1|vanR-C|vanR-C|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-C|AMR|glycopeptide	43.8	224	230	231	2.35e-59	186
ShaoY_2019_ERR3405992_bin.9_k141_29496_99	NCBI|WP_063856725.1|1|1|vanR-C|vanR-C|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-C|AMR|glycopeptide	43.8	224	230	231	3.33e-59	185
ShaoY_2019_ERR3405992_bin.9_k141_29496_99	NCBI|WP_034872470.1|1|1|vanR-C|vanR-C|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-C|AMR|glycopeptide	43.8	224	230	231	4.72e-59	185
ShaoY_2019_ERR3405992_bin.9_k141_29496_99	NCBI|WP_063856726.1|1|1|vanR-M|vanR-M|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-M|AMR|glycopeptide	44.0	225	230	232	9.75e-59	184
ShaoY_2019_ERR3405992_bin.9_k141_29496_99	NCBI|WP_063856722.1|1|1|vanR-D|vanR-D|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-D|AMR|glycopeptide	43.8	226	230	232	5.54e-58	182
ShaoY_2019_ERR3405992_bin.9_k141_29496_100	megares|MEG_7503|Drugs|Glycopeptide|VanC-type_regulator|VANSC_1	31.0	258	500	354	1.01e-27	112
ShaoY_2019_ERR3405992_bin.9_k141_29496_100	megares|MEG_7501|Drugs|Glycopeptide|VanC-type_regulator|VANSC_1	30.8	266	500	354	1.38e-27	112
ShaoY_2019_ERR3405992_bin.9_k141_29496_100	megares|MEG_7500|Drugs|Glycopeptide|VanC-type_regulator|VANSC_1	30.6	258	500	352	3.39e-27	111
ShaoY_2019_ERR3405992_bin.9_k141_29496_100	megares|MEG_7497|Drugs|Glycopeptide|VanC-type_regulator|VANSC_1	30.6	258	500	376	4.88e-27	111
ShaoY_2019_ERR3405992_bin.9_k141_29496_100	NCBI|WP_034869172.1|1|1|vanS-C|vanS-C|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_histidine_kinase_VanS-C|AMR|glycopeptide	30.6	258	500	376	4.88e-27	111
ShaoY_2019_ERR3405992_bin.9_k141_29496_100	megares|MEG_7514|Drugs|Glycopeptide|VanL-type_regulator|VANSL_1	29.5	244	500	364	1.21e-25	107
ShaoY_2019_ERR3405992_bin.9_k141_29496_100	NCBI|WP_063856745.1|1|1|vanS-L|vanS-L|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_histidine_kinase_VanS-L|AMR|glycopeptide	29.5	244	500	364	1.21e-25	107
ShaoY_2019_ERR3405992_bin.9_k141_29496_100	NCBI|WP_222891058.1|1|1|vanS-P|vanS-P|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_histidine_kinase_VanS-P|AMR|glycopeptide	30.5	226	500	359	1.77e-24	103
ShaoY_2019_ERR3405992_bin.9_k141_29496_100	SARG|gb|AAG05187.1|ARO:3005067|ParS	25.6	273	500	428	3.65e-21	94.7
ShaoY_2019_ERR3405992_bin.9_k141_29496_100	CARD|gb|AEX49906.1|ARO:3003583|basS	27.2	261	500	477	2.92e-19	89.4
ShaoY_2019_ERR3405992_bin.9_k141_29496_101	NCBI|EFF39147.1|1|1|norM-NG|norM-NG|efflux|1|EFFLUX|EFFLUX|sodium-coupled_multidrug_efflux_MATE_transporter_NorM|AMR|efflux	21.2	363	462	459	2.15e-14	73.9
ShaoY_2019_ERR3405992_bin.9_k141_29496_101	SARG|NC_011035.1.6448920.p01	21.2	363	462	459	2.15e-14	73.9
ShaoY_2019_ERR3405992_bin.9_k141_29496_101	SARG|gi|488158065|ref|WP_002229273.1|	20.9	363	462	459	6.75e-14	72.4
ShaoY_2019_ERR3405992_bin.9_k141_29496_101	SARG|gi|488156254|ref|WP_002227462.1|	20.7	363	462	459	2.81e-13	70.5
ShaoY_2019_ERR3405992_bin.9_k141_30180_12	megares|MEG_5400|Drugs|beta-lactam|Penicillin_binding_protein|PBP2_1	30.2	162	941	633	1.84e-15	79.7
ShaoY_2019_ERR3405992_bin.9_k141_30180_29	megares|MEG_6058|Drugs|MLS|23S_rRNA_methyltransferases|RLMH_1	57.2	159	160	159	1.70e-57	176
ShaoY_2019_ERR3405992_bin.9_k141_31488_7	NCBI|WP_063856718.1|1|1|vanR-E|vanR-E|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-E|AMR|glycopeptide	44.4	223	231	229	1.54e-62	194
ShaoY_2019_ERR3405992_bin.9_k141_31488_7	NCBI|WP_034872470.1|1|1|vanR-C|vanR-C|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-C|AMR|glycopeptide	44.1	227	231	231	3.76e-61	190
ShaoY_2019_ERR3405992_bin.9_k141_31488_7	NCBI|WP_063856725.1|1|1|vanR-C|vanR-C|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-C|AMR|glycopeptide	44.1	227	231	231	7.54e-61	189
ShaoY_2019_ERR3405992_bin.9_k141_31488_7	NCBI|WP_005228837.1|1|1|vanR-C|vanR-C|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-C|AMR|glycopeptide	43.6	227	231	231	4.29e-60	187
ShaoY_2019_ERR3405992_bin.9_k141_31488_7	NCBI|WP_011461303.1|1|1|vanR-I|vanR-I|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-I|AMR|glycopeptide	41.7	228	231	232	6.26e-60	187
ShaoY_2019_ERR3405992_bin.9_k141_31488_7	NCBI|WP_063856726.1|1|1|vanR-M|vanR-M|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-M|AMR|glycopeptide	41.6	226	231	232	6.26e-60	187
ShaoY_2019_ERR3405992_bin.9_k141_31488_7	NCBI|AXB64454.1|1|1|vanR-Cd|vanR-Cd|re-structuring_of_the_cell_wall|1|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-G-Cd|AMR|glycopeptide	45.0	229	231	233	6.45e-60	187
ShaoY_2019_ERR3405992_bin.9_k141_31488_7	NCBI|WP_063856724.1|1|1|vanR-L|vanR-L|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-L|AMR|glycopeptide	43.6	227	231	231	1.22e-59	186
ShaoY_2019_ERR3405992_bin.9_k141_31488_7	megares|MEG_7482|Drugs|Glycopeptide|VanL-type_regulator|VANRI_1	41.2	228	231	232	1.78e-59	186
ShaoY_2019_ERR3405992_bin.9_k141_31488_7	NCBI|WP_063856728.1|1|1|vanR-N|vanR-N|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-N|AMR|glycopeptide	44.4	223	231	230	3.35e-59	185
ShaoY_2019_ERR3405992_bin.9_k141_31488_8	NCBI|WP_063856748.1|1|1|vanS-M|vanS-M|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_histidine_kinase_VanS-M|AMR|glycopeptide	27.0	270	484	370	8.45e-26	107
ShaoY_2019_ERR3405992_bin.9_k141_31488_8	NCBI|WP_011461302.1|1|1|vanS-I|vanS-I|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_histidine_kinase_VanS-I|AMR|glycopeptide	26.8	306	484	392	3.22e-24	103
ShaoY_2019_ERR3405992_bin.9_k141_31488_15	SARG|ABV82118	24.8	439	604	639	2.49e-29	122
ShaoY_2019_ERR3405992_bin.9_k141_31488_15	SARG|ZP_03989103	24.7	458	604	639	4.44e-29	121
ShaoY_2019_ERR3405992_bin.9_k141_31488_15	SARG|ABV82120	24.7	458	604	639	4.44e-29	121
ShaoY_2019_ERR3405992_bin.9_k141_31488_15	SARG|gi|1004359922|gb|AMP42228.1|	26.7	454	604	639	1.88e-28	119
ShaoY_2019_ERR3405992_bin.9_k141_31488_15	SARG|ABN79417	26.4	455	604	639	4.46e-28	118
ShaoY_2019_ERR3405992_bin.9_k141_31488_15	SARG|AAO42740	26.4	455	604	639	5.95e-28	117
ShaoY_2019_ERR3405992_bin.9_k141_31488_15	SARG|AY485126.gene.p01	26.4	455	604	639	5.95e-28	117
ShaoY_2019_ERR3405992_bin.9_k141_31488_15	megares|MEG_7175|Drugs|Tetracycline|Tetracycline_resistance_ribosomal_protection_proteins|TETO_1	26.4	455	604	639	5.95e-28	117
ShaoY_2019_ERR3405992_bin.9_k141_31488_15	megares|MEG_7169|Drugs|Tetracycline|Tetracycline_resistance_ribosomal_protection_proteins|TETO_1	26.4	455	604	629	7.64e-28	117
ShaoY_2019_ERR3405992_bin.9_k141_31488_15	megares|MEG_7170|Drugs|Tetracycline|Tetracycline_resistance_ribosomal_protection_proteins|TETO_1	26.4	455	604	629	7.64e-28	117
ShaoY_2019_ERR3405992_bin.9_k141_31488_109	megares|MEG_4309|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	33.9	496	518	655	1.24e-88	284
ShaoY_2019_ERR3405992_bin.9_k141_31488_109	megares|MEG_4304|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	33.7	496	518	655	1.74e-88	284
ShaoY_2019_ERR3405992_bin.9_k141_31488_109	SARG|gb|AKA86814|ARO:3003746|optrA	33.7	496	518	655	1.74e-88	284
ShaoY_2019_ERR3405992_bin.9_k141_31488_109	megares|MEG_4306|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	33.9	496	518	655	2.44e-88	283
ShaoY_2019_ERR3405992_bin.9_k141_31488_109	megares|MEG_4313|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	33.7	496	518	655	4.79e-88	283
ShaoY_2019_ERR3405992_bin.9_k141_31488_109	megares|MEG_4312|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	33.7	496	518	655	4.79e-88	283
ShaoY_2019_ERR3405992_bin.9_k141_31488_109	megares|MEG_4315|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	33.7	496	518	655	4.79e-88	283
ShaoY_2019_ERR3405992_bin.9_k141_31488_109	megares|MEG_4307|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	33.7	496	518	655	6.72e-88	282
ShaoY_2019_ERR3405992_bin.9_k141_31488_109	megares|MEG_4323|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	33.7	496	518	655	9.42e-88	282
ShaoY_2019_ERR3405992_bin.9_k141_31488_109	megares|MEG_4318|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	33.5	496	518	655	3.64e-87	280
